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Introdução: O uso de nanopartículas como antimicrobianos pode ter o 
potencial de superar algumas limitações associadas aos antibióticos, tal 
como o aparecimento de estirpes bacterianas resistentes a estes. 
Nanopartículas de prata e, em menor extensão, de cobre tem sido 
amplamente usadas com esta finalidade. Apesar de a prata apresentar maior 
actividade antimicrobiana, esta não tem qualquer função biológica no 
organismo, sendo potencialmente mais tóxica que o cobre. Embora as 
nanoparticulas de cobre sejam menos eficazes, estas são uma potencial 
alternativa devido ao baixo custo de produção e ao facto de serem mais 
biocompatíveis.  
Objectivo: Síntese de novas nanopartículas de hidróxidos de cobre, de 
tamanho pequeno (<10nm) e desenvolvimento de um método de analise da 
actividade antimicrobiana das nanopartículas. 
Parte Experimental: As nanopartículas de hidróxidos de cobre foram 
sintetizadas usando ligandos, tais como o ácido málico, cítrico, tartárico e 
adípico. Tentativas de modificar as nanopartículas originais foram feitas 
usando um tratamento térmico e sílica. A actividade antimicrobiana foi 
testada num ensaio usando E.coli NCTC 11100 em placas de 96 poços. 
Resultados e discussão: As nanopartículas de hidróxidos de cobre foram 
sintetizadas usando ácido tartárico e ácido adípico com um elevado 
rendimento (>90%), tamanho pequeno (3-5nm) e elevada dispersibilidade. 
Em baixas concentrações no meio de cultura bacteriano, as nanoparticulas 
mostraram estar solúveis, sendo que as modificações feitas não foram 
capazes de ultrapassar este problema. Um método para testar a actividade 
antimicrobiana de diferentes compostos foi desenvolvido, mostrando que 
tanto as nanopartículas de hidróxidos de cobre como cloreto de cobre 
mostraram semelhantes reduções no crescimento de E.coli.  
Conclusão: Estes resultados sugerem que as nanopartículas de hidróxidos 
de cobre estavam solúveis no meio de cultura bacteriano e possivelmente, 
a actividade bacteriana observada deveu-se a cobre solúvel. Ainda assim, foi 
desenvolvida uma novo metodologia de síntese de nanopartículas de 
hidróxidos de cobre que poderá permitir no futuro a síntese de nanopartículas 
mais estáveis. Por último, foi desenvolvido um método para testar a
actividade antibacteriana de diferentes compostos, que permite obter um 
grande número de resultados no mesmo ensaio. 
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abstract 
 
Introduction: The use of nanoparticles as antimicrobials has the potential to 
overcome some limitations associated with antibiotics, such as the appearance 
of antibiotic resistant bacterial strains. Silver and, in lesser extents copper 
nanoparticles have been widely used nanomaterials for this purpose. Silver 
has shown higher activities, but it has no biological role in the organism and 
appears to be more toxic than copper. Copper-based nanoparticles, although 
less effective are a potential alternative as they incur a lower manufacturing 
cost and should be more biocompatible. 
Aim: Synthesis of novel copper hydroxides nanoparticles, of a small size
(<10nm) and development of an antimicrobial activity assay to test the efficacy 
of nanoparticles. 
Methods: Copper hydroxides nanoparticles were synthesized using ligands, 
such as malic, citric, tartaric and adipic acid. Heat treatment and silicon 
modifications were attempted to modify the original synthesized nanoparticles. 
The antibacterial activity was tested in a 96 well plate assay using E.coli NCTC 
11100.  
Results and discussion: Copper-based nanoparticles were synthesized using 
tartaric and adipic acid at a high yield (>90%), small size (3-5nm) and well 
disperse. The nanoparticles appeared mostly soluble in broth at low 
concentrations, and the modifications attempted did not overcome this 
problem. An assay to test antimicrobial compounds was developed showing 
that copper chloride and the synthesized nanoparticles affected E.coli growth
similarly. 
Conclusion: The results suggested that copper hydroxides nanoparticles were 
soluble in bacterial culture, and probably the antibacterial activity was due to 
soluble copper, but a synthetic methodology for the synthesis of copper 
hydroxide nanoparticles was established and will allow further refinement to 
generate more stable nanoparticles. Also, a high throughput assay to test 
antibacterial compounds was developed.  
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1. Introduction 
 
1.1. Placement at Medical Research –Human Nutrition Research 
 Medical Research Council is a medical research organisation created in the beginning 
of the XX century. Since that time, the MRC has grown and, currently is composed by 3 
institutes, 27 units and 28 centres all over United Kingdom. The mission of MRC comprises 
the improvement of human health, developing skilled researchers and supporting research in 
different areas, such as cancer, obesity, ageing, stem cells and DNA. From a long time ago, 
MRC scientists have been awarded with the highest distinctions in their areas, including 29 
Nobel Prizes. Frederick Hopkins, Alexander Fleming, Hans Krebs, Frederick Sanger, Francis 
Crick, James Watson, Maurice Wilkins are examples of worldwide famous scientists 
responsible for great findings in areas such as medicine, physiology or chemistry.  Recently, in 
2009, Venkatraman Ramakrishnan won the Chemistry’s Nobel Prize for his work with 
ribosomes at MRC Laboratory of Molecular Biology in Cambridge. Cambridge arises as one of 
the main locations of MRC with more than 10 units and centres, such as the MRC-Human 
Nutrition Research (HNR). MRC-HNR was established in 1998 and is based on Elsie 
Widdowson Laboratory. The unit aims to advance knowledge between human nutrition and 
health and, for that reason is divided in 5 sections: Population Nutrition Research that assesses 
and analyses dietary intakes and relationships to biomarkers and disease; Nutrition and Health 
that studies the role of dietary factors in the prevention and treatment of obesity and related 
metabolic diseases; Nutrition and Bone Health, that looks at nutrition and lifestyle factors for 
the optimisation of peak bone mass and reduction of osteoporosis risk; Bioanalytical discovers 
and measures physiological markers in nutrition and health and lastly Biomineral Research 
which investigates the uptake, distribution, cellular handling and functional role of 
micronutrients. During my placement I worked in the last group, headed by Dr. Jonathan 
Powell, which focus on five essential topics, (i) the development of novel mineral structures, 
(ii)  the study of iron metabolism and the development of strategies to correct iron deficiency 
anaemia, (iii) the study of exogenous and endogenous particles of the gut lumen and their 
cellular target in gut tissue, (iv) also the characterisation of a silicon deficiency and its dietary 
requirements, and finally, (v) the development of methodology to analyse different circulating 
components in human body samples. Biomineral Research group is composed by a group of 10 
scientists, 7 PhD students from the University of Cambridge, and several placement students 
form different universities in Europe. This project was aimed at synthesize novel mineral 
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structures, and in particular copper hydroxides nanoparticles to be potentially used as 
antimicrobials. These novel materials should ideally be easy to prepare, at low cost, should 
remain stable and, also have the potential for production at a large scale.  Also, during the 
project was aimed the development of a method to test the antimicrobial activity of different 
compounds, including the nanoparticles.  
 
1.2. Reasons behind the project 
Nanotechnology is an area in a great development and the number applications of 
nanoproducts have been increased quickly. One of these applications is the use of metal 
nanoparticles as antimicrobials. Since a long time ago that has been known that bacteria are 
able to acquire resistance against antibiotics. Also, some of the effective antibiotics can present 
harmful side effects, especially when over-used, which is a reason for health concern. 
Alternatives to some antibiotics are currently under development, in which copper and silver 
arise as very well-known antimicrobials and recently has been shown that their activity may be 
increased by using nanoparticulated forms of these metals. This finding may lead to the use of 
copper and silver in lower concentrations than they have been used so far, which may avoid 
health safety issues. In particular, silver has been the most studied compound, because it 
presents higher antimicrobial activity than copper, but some studies have shown that silver can 
be toxic for several cell lines in human tissues, even at very low concentrations. Furthermore, 
silver is not apparently used by the organism, being less tolerable than copper and tends to be 
accumulated in the tissues, which can be a reason of concern after long exposure times. In 
contrast, copper is considered a micronutrient, because the organism requires its uptake daily, 
due to the important role in human metabolism, such as showed by the large group of copper-
dependent enzymes in the organism. Also, human tissues have mechanisms able to control the 
copper homeostasis, by regulation of uptake and excretion, which may reduce the risk of 
accumulation and toxicity, even after long exposure times. In a different perspective, copper is 
also much cheaper than silver. Finally some studies comparing copper and silver reported that 
the difference between antimicrobial activities were not very remarkable. The synthesis of 
copper nanoparticles is very well-reported and different copper compounds can be synthesized 
at nanoscale. Also, nanoparticles can be modified to obtain desirable properties to improve 
their effectiveness. For that reasons, the aim of the work was the synthesis of stable copper-
based nanoparticles, in particular copper hydroxides, with antibacterial activity. The topics 
introduced here will be more extensively described during the background.  
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2. Background 
Particles that have typical dimensions between 1-100 nm are often called nanoparticles 
and show distinct properties from those of the bulk analogues. Although these particles have 
always occurred naturally, the nanotechnology only arose few years ago. One of the main 
reasons of these recent developments was the lack of previous suitable characterization 
techniques. Their study has grown because their size leads to a very high surface-volume ratio 
that may be one of the most important factors for their special properties, such as the increasing 
in chemically reactive and catalytic. For example, a decreasing of 10m to 10nm represents an 
increase of 109 in surface area. The higher reactivity of nanoparticles due to the smaller size, 
may be explained by different reasons, such as the higher proportion of atoms at the surface, 
the influence of thermodynamics of chemical reactivity by different surface free energy, 
modifications in atomic structures, different bond lengths or bond angles, and finally 
modifications on the electronic structure of the materials [1]. These dramatic changes, when 
compared with microparticles allow new applications, and currently there are a large range of 
uses in areas such as medicine, food industry, clothing, hygiene and many others [2,3]. To put 
in perspective human cells are typically 10m and most proteins are around 5 nm.  
Nanoparticles may be included in the large concept of nanotechnology, which have 
arisen in the last years as one of the main areas of research. Nanotechnology is briefly defined 
by “engineering at nanoscale”, including the development of nanomaterials to be applied in 
different areas [4]. The importance of nanotechnology emerges, since the development of new 
materials associate the understanding of the main scientific area, such as physics, chemistry, 
biology and materials (Figure 1). The development of nanoparticles includes not only the 
knowledge required in materials for the synthesis and manipulation, but also the understanding 
of physical and chemical properties of synthesized materials to know how to apply in different 
areas, such as biology. In particular, medicine has been one of the most relevant areas in which 
nanomaterials have been developed to be applied. The use of nanoparticles in medicine has 
been especially associated with diagnosis and therapy, being used in the development of 
analytical techniques and also in drug delivery methods to increase the efficacy of the 
treatments used [5]. Some examples of nanoparticle-based products that are currently 
commercialized for medicine purposes are described in the Table 1.  In particular, relating the 
increase of interest of nanoparticles in medicine, copper nanoparticles are one great example of 
that, as seen in Figure 2, which showed the increase of publications about copper nanoparticles 
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as antimicrobials in the last years. Only, in 2010 and 2011 were released 49% of the total 
publications in this topic.   
 
 
Figure 1- The development of nanomaterials involves the knowledge of different areas, such as 
chemistry, biology, physics and materials [6].  
 
 
 
Figure 2- Number of publications that were published in ISI Web of Knowledge database, reporting the 
antimicrobial activity of copper nanoparticles in the last years. Numbers of publications in  2011 was 
obtained only for the first 6 months of the year, using the keywords:  i) copper + nanoparticles + 
antibacterial or ii) copper + nanoparticles +  antimicrobial.    
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Table 1- Examples of industrial companies actually commercialising nanomaterials for biomedical 
applications [2]. 
 
 
2.1. Bacteria: structure, resistance and occurrence   
The development of antibacterial particles requires the understanding of how they can 
act to avoid the growth or even kill the microorganisms, thus, the understanding of the basic 
structure or vital mechanisms is essential. Bacteria are prokaryotic organisms, and one of the 
characteristics of these organisms is their cell wall that is very important when studying the 
bacteria structure, as it contains some components only present in these microorganisms. Of 
these components, the cell envelope is of particular interest, as it includes not only the cell wall 
but also plasma membrane and usually a capsule outside the cell wall composed by 
polysaccharides [7]. Overall, this structure acts as a protection barrier against external damage, 
avoiding the cellular rupture and consequently death. The constitution of the cell wall varies 
depending on the strain, for example, gram-negative bacteria have a thin layer of peptidoglycan 
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between two membranes, an inner membrane composed by phospholipids and an outer 
membrane containing lipopolysaccharides that are located to the outer leaflet [7]. Gram-
positive have only one plasma membrane protected by a thick peptidoglycan layer that 
surrounds it. This difference in structure is responsible for the different staining properties of 
bacteria, since purple crystal violet is retained by the peptidoglycan layer of gram positive in 
the gram-staining procedure [8]. Also, these bacteria normally have teichoic acids and 
teichuronic acids covalently linked to peptidoglycan. The Figure 1 schematically represents the 
cell envelope of gram-negative and gram-positive bacteria. 
Although it provides protection to bacteria, the cell wall is a preferential place for the 
action of antibiotics due its specific components which are not found in any other organisms. 
Murein is the main component responsible for this specificity, being one of the most important 
differences between bacteria and Archaea cell wall structure. This peptidoglycan is composed 
by a disaccharide polymer cross-linked by peptides, such as D-alanine, L-alanine and L-lysine. 
N-acetylmuramic (M) acid and N-acetylglucosamine (G) are linked between them, forming the 
basic unit of peptidoglycans. The degree of cross-linking is higher in gram-positive cells, 
which occurs between meso-Diaminopimelic acid (mesoDAP) and D-alanine, as seen in Figure 
3.  The bacterial cell wall presents a large number of functional groups in its surface that are 
able to interact with external agents and many antibacterial agents, such as nanoparticles, have 
been reported to inhibit the growth of bacteria through mechanisms associated with the cell 
wall. For example, lysozyme is an enzyme that is present in animal fluids, such as human tears, 
and acts as an antibacterial protector, by breaking down the linkage between NAM acid and 
NAG, thus damaging in the cell wall structure. Also penicillin, a well-known antibiotic, 
inhibits the formation of the cell wall by binding to bacterial transpeptidases responsible for the 
formation of NAG-NAM linkages, thus preventing the normal bacterial growth [8,9].  
Recently, the resistance of many bacterial strains to antibiotics has been a reason of 
concern for human health. The mechanisms of resistance can be intrinsic or acquired. An 
example of intrinsic resistance occurs in Pseudomonas aeruginosa that has a very low 
permeability and consequently, prevents the entrance of most antibiotics [10]. The outer 
membrane of gram-negative bacteria is semi-permeable, and only small antibiotics are able to 
cross this membrane by porin channels, normally used for the uptake of water by bacteria [11]. 
The size of this porin channel excludes, automatically, the larger antibiotics. In particular, the 
porins of Pseudomonas aeruginosa are extremely small, being a strong mechanism of 
resistance for drugs. In addition, these bacteria present another mechanism of resistance related 
with the efflux of the drugs. The cell membranes are able to pump out the antibiotics that had 
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crossed the membrane. Together, both mechanisms are responsible for the high resistance of 
pseudomonas aeruginosa to antibiotics [10].  
 
 
Figure 3- Schematic structure of gram-negative (left) and gram-positive (right) cell wall and respective 
peptidoglycan composition (left). Abbreviations: LTA, lipoteichoic acid; LPS, lipopolysaccharide; TA, 
teichoic acid; M, N-acetylmuramic; G, N-acetylglucosamine. Adapted from[12]. 
 
Acquired resistance is commonly related to genetic mechanisms. The development of 
enzymes that is able to inactivate antibiotics, such as -lactamase that degrades the -lactams, 
inhibiting their activity against bacteria [13].  Furthermore, the bacteria are able to acquire new 
genes, on plasmids, that lead to the modification of metabolic enzymes. These modifications 
prevent the binding of antibiotics to the enzymes, avoiding their inactivation, thus keeping the 
normal bacterial growth [13]. Besides Pseudomonas aeruginosa, also Streptococcus pyogenes, 
Staphylococcus aureus and Escherichia coli are examples of resistant bacteria, which have 
been studied to develop new effective antibiotics, to overcome serious health problems related 
to their pathogenicity. 
The understanding of the metabolic pathways of some important pathogenic bacteria, 
which are responsible to cause diseases in the human body, is important to develop effective 
metal nanoparticles against these microorganisms. Both, skin and gut are main possibilities for 
the application of antibacterial nanoparticles and they present a variety of microorganisms in 
the normal flora. The human flora can be defined as the microorganism present in healthy 
tissues, such as gut or skin surface. The skin is the largest organ in the human body and is the 
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first physical barrier to the entrance of pathogenic organisms, which can cause infections. The 
pH of the skin surface (5-6) is important in this protection, as it prevent the growth of most of 
the microorganism. The low pH is due to the presence of acids, normally fatty acids, produced 
by bacteria of skin flora. Also, some bacteria of normal flora, such as Staphylococcus 
epidermis and Propionibacterium acnes, are able to produce some antibiotics that prevent the 
infection with pathogens [14]. The most common bacterial skin infections are related with 
Staphylococcus aureus and different forms of Streptococcus. In the gut, especially in colon, the 
flora present is very large and diverse. This flora is very important for the human body as it 
prevents infection by pathogenic bacteria, through the formation of a barrier in intestinal 
mucosa that avoid the invasion of pathogens. Also, controls the proliferation and differentiation 
of epithelial cells, is responsible for fermentation of carbohydrates that are not degradable by 
the human enzymes, and finally can interfere in immune response [15].  One of the most 
dangerous pathogens in the intestine is the Clostridium difficile, which can be responsible for 
serious infections of the colon. Also, the contamination of food products can lead to bacterial 
infections in the intestine. Salmonella, Listeria monocytogenes, Campylobacter or E. coli O157 
are examples of strains, which usually cause disease in humans. 
As described previously, many microorganisms have developed resistance mechanisms 
to antibiotics in short periods of time [16]. The effort involved in the development of new 
effective antibiotic shows that copper is a great alternative, due to its easy interaction with 
bacteria [17], and although it has used by mankind for antimicrobial purposes since thousands 
of years ago and it is still extremely rare to find any tolerant microorganisms. In particular, 
copper nanoparticles possess the advantages of copper salts but and may be able to reduce the 
toxicity risks associated to metallic copper while enhancing their antimicrobial activity.  
 
2.1.1. Escherichia coli 
E.coli was chosen as a model bacterium due to being well reported in the literature, 
making result comparison possible and, also, to adapt existing microbiological methods to the 
current project. E.coli is a very well-studied gram-negative bacterium that is a member of the 
family Enterobacteriaceae, which is composed by facultative anaerobic bacteria that generally 
compose the human flora. Thus, E.coli is able to grow whether in the presence of oxygen or 
under anaerobic conditions, such as in the human intestine, where this bacteria have been 
identified as one of the main populations. Most of the strains are not pathogenic, especially the 
ones present in the human intestine, which may present advantages to the hosts, such as the 
synthesis vitamin K and another important molecules for human compounds [18]. Also, the 
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fixation in the intestinal mucosa may lead to prevent pathogenic bacteria to access the human 
mucosa to attach and colonize there [19]. In contrast, some strains of bacteria can be highly 
pathogenic, being responsible for several diseases in human, such as diarrhoeas, 
gastrointestinal and urinary infections. In some cases, an infection with E.coli may lead to 
death, for example, by production of endotoxins that are released in the human body or by 
invasion and infection of the cells causing their death. Furthermore, these bacteria are normally 
very resistant even in hostile environments, as seen in some parts of intestine, where E.coli is 
able to grow even with lower amounts of nutrients [20]. Overall, E Coli is a good test 
bacterium and was used in the antimicrobial efficacy assays.   
 
2.2. Copper, nanoparticles and antimicrobial activity 
Metal ions such as silver, copper or zinc have been largely reported as antimicrobials 
and highly used for this purpose. The bactericidal effect of these metals is very well known and 
has been studied from a very long time ago, due to many possible applications. Not only the 
metal ions, but also different metal compounds have been used as antimicrobial in usual daily 
products. Associations with polymers, fixation in gels matrixes or even some crystalline forms 
are common examples of the occurrence of these metals that are used in medical (e.g. burns 
treatment) or feed applications (e.g. packaging). Despite a reasonable understanding of 
antimicrobial action of metals, most mechanisms of action still remain partially unknown.  
The high activity of nanoparticles against microorganisms has been proposed to be due 
to their small size and high surface volume that leads to a closer interaction with bacterial 
membranes, generally better than the effect produced by isolated metal ions in solution [21,22]. 
This fact may be the key for the success of metal nanoparticles against the corresponding ionic 
forms. Many papers have been published demonstrating that same metals could present 
different activities depending on the characteristic of the particles, such as shape or size. For 
example, a study realized with silver nanoparticles against E.coli revealed that spherical and 
triangular shapes were the most effective [23]. Also, size is very important, and smaller 
particles have higher activity, probably due to the high surface area, and closer interaction, as 
mentioned above. The use of smaller nanoparticles can result in the same antimicrobial 
effectiveness with lower concentrations of metal, which is very important, not only 
economically, but also decreasing the possible toxicity and environmental risks involved with 
metal compounds. 
Silver nanoparticles have been the most widely studied antimicrobial nanoparticles, as 
they present the highest activity against most microorganisms [24-28]. Nevertheless their use 
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presents some limitations such as potential toxicity and high cost. Environmental risks that are 
associated with silver are also of concern and may result in greater control of its utilization  
[29,30]. Silver has not any known utilization in human body, which reduces the potential for 
biocompatibility. As the silver is not metabolized, its intake can lead to the accumulation in 
human tissues, being a great concern for long exposition times. Silver is mostly absorbed in 
organism in intestine and then transported into blood, where the silver can be transported by 
albumin or as a free ion. Often, some silver salts are able to corrode the intestinal mucosa, 
increasing the permeability and consequently absorbing higher amounts of compounds 
including silver. High amounts may lead to silver precipitation in blood, or can be transported 
to different tissues, such as brain, skin, nails, kidney or spleen. Silver is not metabolized by the 
organism and tends to be accumulated in these tissues, and may be toxic for the cells [31]. 
Studies in mammal cells have shown cytotoxicity, mainly related with mitochondrial damage, 
by generation of reactive oxygen species, which may affect the production of ATP and activate 
the cell apoptosis regulators [32]. Also, DNA can be damaged, being silver considered 
cytotoxic and genotoxic [33,34]. The authors of these studies considered that silver 
nanoparticles can enter in the cell by diffusion or endocytosis causing the production of 
reactive oxygen species (ROS) that will affect the mitochondria. Also, some silver ions may be 
released and cross the nuclear membrane causing DNA damage and inducing cell apoptosis 
mechanisms. An example of consequence of extreme intake of silver is argyria, which is a 
pathological effect caused by exposure of silver, which is accumulated in different tissues of 
the organism, particularly in the skin, forming granules that confer the grey appearance to the 
patients. The constitution of granules is mainly silver sulphides and normally argyria did not 
show physiological problems for some tissues, which may mean that this is a detoxification 
mechanism of the body, because it avoids the negative effects of silver in cells. Argyria has no 
efficient treatment known, so far. [35]. Also, some topical deliver of nanoparticulated silver 
showed toxicity to skin tissues, including keratinocytes and fibroblasts when absorbed through 
the skin [36].  Furthermore, silver can cross the blood-brain barrier and accumulate in the 
central nervous system. Generally, there are several reports of toxicity of silver in different 
tissues and cell lines, as seen in Table 2. Although the high potential use as bactericidal 
compounds, a different strategy is required.  
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Table 2 –Toxicity of nanosized silver compounds in mammalians cells, including some human cells 
types [32].  
 
 
To avoid these problems the use of lower toxic metallic particles might be an 
alternative. Copper arises as an essential micronutrient, being required a daily intake for the 
normal functionality of the body. Copper’s intake is especially taken by ingestion of food 
containing copper. Also, copper can be absorbed in very low amounts through the skin [37]. 
The copper is not soluble at physiological pH, which leads to appear in very lower 
concentrations in the free ionic form, Cu+ and Cu2+. Thus, copper appears normally associated 
with transport molecules, commonly bound by proteins, or smaller chelating agents, such as 
aminoacids. In the organism, copper is absorbed especially in stomach and small intestine. 
Particularly, in the intestine, copper diffuses through the mucosa into interstitial fluid and 
blood. If present in higher concentrations, copper can be absorbed by carrier-mediated systems 
used for different transition metal ions, such as zinc or iron. This competitive mechanism of 
absorption may lead to deficiency in some compounds due to the presence of one in higher 
amounts. On the other hand the efficacy of copper absorption in intestinal mucosa can be 
controlled by the body when the amount of copper ingested exceeds the normal concentration. 
The absorption of copper is normally between 55% and 75%. Once absorbed across the 
intestinal mucosa, copper binds to proteins, in particular to albumin and transcuprein, to be 
taken to the liver. Transcuprein has higher specificity for copper than albumin, which is the 
main protein present in blood, responsible for the transport of several components, so not 
specific for copper. In the liver, copper will be used for several purposes, such as synthesis of 
different copper-containing proteins, such as superoxide dismutase and cytochrome oxidase 
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and metallothionein. The role of copper in organism is partially related with these three 
proteins, because their functionality requires copper. Superoxide dismutase is an important 
enzyme in the control of oxidative homeostasis, being responsible for conversion of superoxide 
in hydrogen peroxide and oxygen Cytochrome oxidase is an enzyme of the electron transport 
chain in mitochondria which is involved in the reduction of oxygen to water, using electrons 
coming from the previous complexes. Lastly, metallothionein is a low-molecular weight 
protein that is used s oxidative stress scavenger, especially by degradation of superoxide, but 
can also be used for copper storage, when this metal is present in higher amounts than required 
and was not utilized by the organism. Also, other copper-dependent proteins can be 
synthesized in the liver as shown in the Table 3 [38]. Special emphasis is given to 
ceruloplasmin, which is an important transport protein synthesized in the liver, where that 
copper is added during this process. This protein transports copper to different body tissues, 
such as brain and muscles. Ceruloplasmin is also important in the iron metabolism by oxidizing 
Fe2+ to Fe3+, which enables the binding of transferrin. If copper did not reach the liver and was 
not absorbed at all, it is taken directly to faeces. Often, copper can also be taken to different 
tissues in body by albumin and transcuprein. Copper that leaves the liver, transported by 
ceruloplasmin, can be excreted directly to urine, but mostly, copper is excreted by bile fluids, 
which present the highest amount of copper in the body, and are able to excrete copper by 
faeces. If required, copper can be reabsorbed in the intestinal tract and taken back to liver, 
being this mechanism very important in copper homeostasis [39]. The overall metabolism of 
dietary copper is schematized in Figure 4. 
As seen, copper has an important role in organism, also some mechanisms of excretion 
that have emerged as possible protection against toxicity [40]  Comparing with copper, it is 
important to consider the cost, being the copper much cheaper than silver, which allows its use 
at industrial scale at lower cost. Consequently at commercial level becomes much more 
promising too. Finally copper compounds present stable physicochemical properties and can be 
easily modified as will be seen below [18]. 
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Figure 4 - Dietary copper metabolism in human body [39].  
 
Table 3- Copper-dependent proteins in mammals [38]. 
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2.2.1. Antimicrobial compounds   
As mentioned above, copper is an antimicrobial compound and to understand its 
mechanism of action and efficacy will be briefly described about antimicrobials already used 
and including metal nanoparticles. Antimicrobials are compounds that kill or inhibit the growth 
of microorganisms, and understanding the physiological mechanisms of these microorganisms 
is the first step in development of an agent that is effective against them. Therefore, to kill or 
inhibit bacteria the antimicrobial must be able to disrupt some vital components of the 
metabolic pathways of bacteria, thus hindering their homeostasis. Table 4 shows some 
antibiotics currently used and their physiological target in bacteria that could lead to their 
growth inhibition or even death.  
Antimicrobial agents must also be delivered in the target place, and also they must act 
on the target bacteria. Some antimicrobials have a reduced range of bacteria against which they 
are very effective. The metal nanoparticles can be the alternative to overcome this limitation of 
antibiotics, due to their activity against some drug resistant bacteria. For example, silver 
nanoparticles showed bactericidal effect against methicillin-resistant Staphylococcus aureus, 
ampicillin-resistant Escherichia coli O157:H7, erythromycin-resistant Staphylococcus 
pyogenes and multidrug-resistant Pseudomonas aeruginosa. Also, strains of these types of 
bacteria that are susceptible to antibiotics were tested. Comparing the antibacterial activity, 
there are no remarkable differences between drug-resistant and drug-susceptible strains, which 
can indicate that the resistance mechanism did not affect the efficacy of nanoparticles [27].  
 
Table 4- Various antimicrobials and their mechanisms of action in bacteria. 
 
Antimicrobial Effect produced in bacteria 
-lactams (Penicillin,  
cephalosporins) 
 
Inhibit of bacteria cell wall 
synthesis 
Tetracyclines, macrolides, 
clindamycin 
 
Inhibit protein synthesis 
Quinolones and 
metronidazole 
 
Inhibit nucleic acid synthesis 
Sulphonamides and 
Trimethoprim  
Inhibit enzyme synthesis 
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The mechanism of copper nanoparticles is partially unknown, although it has been 
compared with the mechanism proposed for silver nanoparticles. The silver nanoparticles have 
been proposed to act via three different pathways, uptake of free silver ion released from 
nanoparticles, by generation of ROS or direct damage of cell membranes by nanoparticles 
(Figure 5). The first proposal requires the release of silver ions in the cell membrane of 
bacteria, which sometimes cannot occur in physiological conditions, because it requires 
strongly oxidative environments. Once released, the Ag+ ions may bind proteins, through the 
thiols groups of some aminoacids, which may lead to the disruption of activity of proteins, 
including some enzymes that may lose completely their catalytic activity. In particularly, 
respiratory chain enzymes may be one of the most affected proteins in cell, with serious effects 
on ATP synthesis. Also, Ag+ may affect the homeostasis of phosphate, inhibiting the uptake of 
this compound [41]. Although similar to action of silver salts, the prolonged release of silver 
(I) ions from nanoparticles may lead to longer exposure times and subsequently greater 
affinity. 
A second proposal is the generation of ROS by the presence of silver compounds, 
whether nanoparticles or ions. In the presence of oxygen and silver can be produced free 
radicals responsible for the oxidative stress in cells. Furthermore silver may be also responsible 
for the inhibition of oxidative scavengers, such as glutathione. Increasing the ROS and 
decreasing the oxidative defenses will expose the cell to a hostile environment that probably 
leads to several damages in important structures, such as mitochondria and cell membrane, 
which may cause the cell death [32].  
The third proposed mechanism is related with the direct damage of cell membrane by 
nanoparticles, which can be tackled by the interaction and penetration of nanoparticles in the 
bacterial envelope, creating pits or even holes, which cause the cell death [42]. Often, smaller 
nanoparticles were detected intracellularly after damaged the cell membrane [43]. The 
interaction between cell and nanoparticles is possibly due to electrostatic interaction between 
the positive nanoparticles and the negative bacterial membrane, which may explain some 
reports of coated nanoparticles that presented reduced activities, probably due to the decreased 
affinity between nanoparticle and bacteria caused by the incorporation of a coating [42].  
Another effect caused by the presence of particles in the surface of bacteria is an increase in 
permeability of membrane [43].  
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Figure 5- Three different proposed mechanism of silver nanoparticles action: Release of silver ions, 
generation of ROS and direct cell membrane damage [32].  
 
 
Although some mechanisms of copper ions have been already described, there are a 
limited number of studies reporting the mode of action of copper nanoparticles, and may be 
speculated that mechanisms of silver nanoparticles may be applicable for copper nanoparticles 
[25]. The biocide effect of copper ions is well known and has been related with the inactivation 
of biological functions of microorganisms. The envelope is the first part of bacteria in contact 
with copper, being the point of adhesion via electrostatic forces of copper ions. The extensive 
amount of copper leads to disruption of membrane and consequently loss of viability [16]. 
Also, copper can be transported inside the cell, and can interact with proteins and nucleic acids. 
The interaction with proteins can occur by binding directly to aminoacids of protein or by 
displacement of metal from their native binding sites in metallic proteins, which normally leads 
to structural modifications. These changes can cause the loss of biological activity of proteins, 
by inactivation of important metabolic routes and often with cell death. Also, DNA can be 
damaged by copper, which is able to create cross linkages in DNA strands leading to 
denaturation. Mechanisms involving free radicals generated by copper have been proposed, in 
particular, the catalysis of hydroxyl radical formation (.OH), which is responsible for several 
damages in important biomolecules, such as proteins and nucleic acids [44,45]. Although the 
antimicrobial effect of copper ions, the lower efficacy, comparing with nanoparticles, may be 
due to bacterial resistance mechanism proposed specific for copper ions. Some bacteria, such 
as E.coli, are able to control the uptake and excretion of copper. The mechanism of copper 
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intake by bacteria is still not completely known, but some relevant homeostasis mechanisms 
have already been proposed, in which copper can be taken up by bacteria through an ATPase 
system that is specialised for the transport of cations, such as copper, magnesium or silver, 
across the cell membrane. This ATPase is being called by P-type ATPase due to the 
phosphorylated intermediary that forms during the mechanism [46]. The ATPase’s are 
generally a system of proteins located in the cell membranes that are responsible for the 
transport of compounds through the membrane and involves the use of ATP. ATPase 
specialized for the transport of copper, normally, have several transmembranar protein domains 
and some extracellular domains responsible for the binding of copper. CPx motif is one of 
these extracellular domains that are responsible for the binding of copper, and was shown a 
similar structure in humans which has an important role in copper deficiency diseases in 
humans, if not working properly [47]. There are two transmembranar ATPase channels 
responsible for the transport of copper, CopA, where the copper is uptaked and CopB that 
excretes copper out of the cell [48]. The homeostasis is controlled by the level of copper, if in 
excess, copper could cross the cell membrane through CopA or porins, which is coupled to an 
intracellular protein, CopZ, that binds copper, and transfer the copper to a zinc-containing 
protein that binds DNA (CopY). When CopY binds copper, zinc is released, losing the affinity 
to bind DNA, and is not able to bind the promoter and repress the expression of CopB to 
excrete copper (Figure 6). Then copper may be transported to CopB by molecules, such as 
glutathione (GSH). Lower concentrations of copper do not enable the transfer of copper from 
CopZ to CopY, which binds the promoter, and represses the expression of CopB, keeping the 
copper intracellularly [49].  
 
 
Figure 6 – Copper homeostasis mechanism in bacteria [49].  
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 The mechanism uses preferentially Cu+, a reduced ion of copper ions, which tends to 
oxidize to Cu2+, but some mechanisms have been reported where copper reduction allows 
uptake and transport in bacteria, by a cupric reductase called NDH-2 [50]. Furthermore, silver 
seems to be able to use the same mechanism to be uptaked by bacteria, by the possible lower 
affinity may explain the high toxicity caused by silver. Copper can be taken up by bacteria 
using other transporters, but the mechanisms remain mostly unknown, and also seem to have a 
small influence in the overall homeostatic mechanism [48]. These mechanisms are directly 
associated with bacterial resistance against ionic copper, and it could be the reason for the 
lower activity of ionic copper, comparing with copper nanoparticles that may present a 
different mechanism of uptake by bacteria, these resistance mechanisms cannot protect 
bacteria. As mentioned above, these mechanisms have been proposed to be related with the 
bacterial cell wall, and often the death of bacteria is associated with damages in this structure in 
a similar fashion of silver nanoparticles. The metal catalysis of reactive oxygen species (ROS) 
is also involved sometimes, where the metals interacts with the cell membrane initiating a 
cascade of intracellular reactions affecting the permeability of the membrane. A different 
theory reports that metal nanoparticles are able to interact with thiol groups of proteins, due to 
the high affinity of metal to sulphur compounds, which leads to their inactivation and 
consequently loss of functionality of proteins, including enzymes. This mechanism is 
especially effective if the respiration or transport across the membrane is affected [17]. Finally, 
a mechanism of slow release of metal ions from nanoparticles was proposed, but the activity of 
metal nanoparticles has been reported to be higher than the corresponding metal ions what 
leads to believe that the mechanism is not merely involving the soluble metal ions, which is 
supported by the resistance mechanism against copper ions described [51].  
 
2.2.2. Copper nanoparticles 
 Copper is a transition metal that has been used by mankind for more than six thousand 
years. Its use is related with the properties of copper, such as high electrical conductivity, 
resistance, recyclability and durability, being applied in several areas, such as constructions, 
transports, electrical applications or even as a coinage metal [52]. Copper compounds, such as 
copper sulphate or copper chloride and copper hydroxide, are largely used in agriculture as 
herbicides, fungicides and pesticides, being considered safe, because they do not penetrate the 
plant tissues [53]. Antimicrobials are one of the main copper applications, being this metal 
used as biocide since the ancient Egypt, at 2000 BC [16].  
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 The antimicrobial activity of copper may appear initially surprising, since this element 
is used by most organisms and it seems in fact an essential micronutrient, for example in 
human body, where it has an important role as a catalytic cofactor in different metabolic 
pathways, such as mitochondrial electron transport chain, free radicals scavenging and iron 
absorption, as mentioned above [38]. Despite the copper, gold and silver belong to the same 
group in periodic table, copper is the only one that has an important role biochemically.  
 Copper exists in the oxidation states ranging from +1 to +4, being the cuprous (+1) and 
cupric (+2) by far the most commons forms.  Cu+ is not stable is aqueous solutions, generating 
Cu2+ ions and Cu. Normally, Cu2+ ions generate coloured solutions, due to the absorption of 
radiation in the range of 600-900 nm. Different oxidation states of copper have different 
colours, which allow their use as a sensor of oxidative reactions, such as the Benedict reagent 
that is used to detect the presence of reducing sugars. These sugars are able to reduce Cu2+ 
(blue) to Cu+ (red), and the changing in the colour of the solution give an indication of the 
presence of reducing sugar. Copper oxidizes easily when exposed to oxygen sources, and to 
prepare elemental copper nanoparticles techniques that avoid the oxidation must be used, such 
as synthesis in organic solvents or reduction of produced copper nanoparticles oxidized. The 
use of copper oxides avoids these problems, as their synthesis does not require removing 
oxygen or use of hydrogen or even the utilization of organic solvents to prevent the oxidation 
[52,53].  
 
2.2.3. Synthesis of different nanoparticulated forms of copper   
 The preparation of copper oxide nanoparticles involves the basic chemical reactions of 
copper. These nanoparticles are normally synthesized from copper salts, such as copper 
chloride (CuCl2) and copper nitrate Cu(NO3) [54]. The reaction of these salts with NaOH 
produces copper hydroxides and sodium chloride, as seen in equation 1 and equation 2. The 
obtained solution with copper hydroxides can be heated to obtain copper oxide (CuO), as 
shown in equation 3. These basic, fast and easy reactions are the basic steps used in most of the 
synthesis of copper oxides nanoparticles by wet-chemical reactions. The formation of 
nanoparticles can occur by heating copper hydroxides to obtain the copper oxides. The copper 
hydroxides normally precipitate and the temperature and time of exposition applied influence 
the size and shape of nanoparticles obtained. The transformation of copper hydroxides in 
copper oxide occurs easily by thermal dehydration, due to the formation of a more stable 
oxidative phase. To avoid the use of high temperatures, this reaction takes place in alkaline 
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solutions, where the presence of hydroxyl ions (OH-) can react with copper hydroxide 
producing an anion that easily converts in copper oxide (equation 4) [55].  
 
Equations: 
CuCl2 + 2NaOH   Cu(OH)2 + 2NaCl   (1) 
Cu(NO3)2+2NaOH  Cu(OH)2+2Na(NO3)2    (2) 
Cu(OH)2 heat> CuO+ H2O     (3) 
Cu(OH)2 + 2OH-Cu(OH)42- CuO+ H2O+2OH-  (4) 
 
Low temperatures lead to an incomplete reaction, obtaining heterogeneous particles. On 
the other hand, high temperatures may agglomerate the particles [56]. The production of copper 
nanoparticles in organic solvents is sometimes used to prevent the normal oxidation of copper 
nanoparticles during the synthesis in aqueous solvents. Often, the temperature required in the 
production is lower than the temperatures used in aqueous solutions [57]. For example, 1,2-
propanodiol was used as a solvent, but the synthesis was difficult to control, and the resulting 
particle size was more than 100 nm [58]. 
The synthesis of nanoparticles with controlled size and higher stability can be done 
using templates. Templates are polymeric matrices that provide a good environment for the 
controlled growth of nanoparticles. Copper nanoparticles have been synthesized in different 
templates. Polyethylene glycol was used to prepare copper oxides nanorods from copper 
chloride salts, which were mixed with the polymer. The remaining of the method was similar 
to the wet-chemical techniques described above, addition of NaOH and heating. PEG was 
reported to have an important role in control of the shape of copper oxides. As a non-ionic 
surfactant, PEG permits the growth of nanoparticles along their chains, leading to the typical 
nanorod shape [59]. Also, polysaccharides have been used to prepare the nanoparticles in a 
synthesis defined as “green”, because uses non-toxic chemicals, including organic solvents and 
use renewable materials. The nanoparticles were synthesized in a starch matrix, which was 
mixed with the metal salt and heated up to obtain the nanoparticles. The particle size was very 
small, showing the capacity for size control of the starch matrix [60]. 
The nanoparticles can be synthesized using surface modifications, which provide 
suitable properties for specific applications and also stabilize them, avoiding agglomeration. 
The modifications normally occur by addition of organic groups, containing, for example, 
thiols, amines or carboxylic acids [61]. The surface modifications can incorporate functional 
groups in the surface of nanoparticles, providing the desirable effects. Thiols (R-SH) are 
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molecules containing atoms of sulphur, such as cysteine, that are strongly coordinate by metals, 
including copper. When exposed to these metal, the thiol groups are automatically adsorbed by 
the nanoparticles. The thiols can be used to control the growth of nanoparticles. While the 
nanoparticles are forming and growing, the surface area is decreasing, till the coordination of 
ligands becomes favourable and stops the growth of nanoparticles. Different concentrations of 
ligands allow different particle size [62]. Another, modification are the adsorption of amines by 
metal nanoparticles and is usually used to stabilize the nanoparticles [63]. The interaction of 
amines with metals is weaker than thiols, and therefore originates bigger particles. Compounds 
containing the ammonium ion can also be used, having similar effects of amines.  Also, 
carboxylic acids are able to interact with nanoparticles in solution through the negatively 
charged carboxylate in a similar fashion of thiols. Multiple attachments can increase the 
stability of the nanoparticle. Fatty acids such as palmitic acid and oleic acid, are examples of 
carboxylates ligands that have been used to modify the surface of nanoparticles, allowing the 
control of the size and improving the stability [62,64]. 
 As described, the copper nanoparticles can be synthesized by a large range of 
techniques, depending on the size or shape desired. The synthesis of nanoparticles of different 
metals, such as silver, zinc and iron, can also be adapted to produce copper nanoparticles. The 
use of ligands has also been reported to modify the surface of nanoparticles. An example of 
copper-based nanoparticles is shown in Figure 7. 
 
 
Figure 7- Copper oxide nanoparticles visible in TEM [21]. 
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2.2.4. Antibacterial activity of copper nanoparticles 
 The antibacterial activity of copper oxide nanoparticles has been studied against a large 
range of bacteria. For example, nanoparticles prepared by a new method using thermal plasma 
were tested against different bacteria, such as S.aureus, S.epidermis, E. coli and P. aeruginosa. 
These bacteria are normally associated with hospital acquired infections and some of them are 
multi-resistant against some antibiotics, including strains of S. aureus methicillin-resistant. The 
results showed the effectiveness of copper oxide nanoparticles against all of them, with 
different minimal bactericidal concentrations. The highest activity occurred against S. aureus 
and E.coli. The authors proposed the use of copper nanoparticles in wall coverings, equipment, 
clothing and bedding in hospital [21].  
Antibacterial effect of copper and silver nanoparticles was compared using different 
bacterial species [25,65]. Both copper and silver nanoparticles present a great inhibition of the 
bacterial growth against E. coli, S. aureus and B. subtillis, as seen in Figure 8. The antibacterial 
activity increases with the increasing of metals concentration in bacterial culture, being the 
silver nanoparticles those who present the highest antimicrobial activity, although the 
difference is not too much significant, and in some strains, copper nanoparticles presents 
higher inhibitory growth, as shown in Figure 9. Another interesting finding comes from 
energy-dispersive X-ray spectroscopy analysis, where the presence of oxygen was detected, 
that leads to believe that were used copper oxide nanoparticles [25]. The particle size reveals 
that the silver nanoparticles used were smaller than the copper nanoparticles. The silver 
nanoparticles measured around 3 nm, while the copper ones were around 9 nm, which could 
affect the antimicrobial capacity as explained above. Another report shows a higher activity of 
copper nanoparticles than silver nanoparticles against E. coli and B. subtillis [65]. These 
reports showed that the difference of silver and copper nanoparticles was not remarkable, 
although is known that silver presents much higher activities than copper. The synthesis of 
small copper nanoparticles may improve the antibacterial activity and reduce the difference 
between silver and copper activities.  
Finally, metal nanoparticles including copper were tested against a different 
microorganism, Saccharomyces cerevisiae, a type of yeast, showing high biocide activity. In 
this experiment was tested the toxicity of copper in different forms such as copper oxide 
nanoparticles, ionic copper and bulk copper oxide. The nanoparticles presented the highest 
toxicity [44].   
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Figure 8- Representative batch growth profile in presence of varying concentration of silver/copper 
nanoparticles for (a) E. coli (MTCC 1302), (b) B. subtilis (MTCC 441) and (c) S. aureus (NCIM 5021).  
[25]. 
 
 
 
Figure 9- The graph shows the Diameter of Inhibition Zone (DIZ) surrounding silver and copper 
nanoparticles impregnated disks of 6 mm of diameter in presence of various microorganisms [25]. 
 
 
2.3. Silicon compounds and metal nanoparticles 
Silicon is an atom from the same group of carbon, and presents very special 
physicochemical properties [66]. Silicon has already been used with metal nanoparticles, such 
as, for the formation coatings to protect the nanoparticles [64,67-70]. This compound is a very 
reactive element and is present in many compounds, including silica, whose chemical name is 
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silicon dioxide, SiO2. Also, it is the most common mineral in the Earth’s crust. Both, gel 
formation and coating are the main utilizations of silica with metal nanoparticles due to the 
high affinity of silica for some metals forming complexes with them. Iron, copper and zinc 
nanoparticles are examples of metal nanoparticles already used with silica [64,69-71].  
Metal nanoparticles must be stable to allow their effectiveness in different applications, 
such as catalysis or antibacterial, and modifying the surface of these particles has been reported 
as a successful approach [66,70]. Since the first studies in stability of nanoparticles, silica was 
used to avoid problems related with low stability. For example, the surface of zinc oxide 
nanoparticles (ZnO) was coated with silica improving the dispersibility and reducing the 
agglomeration of nanoparticles [64]. Also, mineral ferrous oxide, in particular magnetite, was 
coated to avoid the formation of different oxidized species, such as the mineral ferric oxides 
hematite and maghemite, showing that silica was able to protect these nanoparticles, even in 
hard conditions, such as very high temperatures [71]. Silica-coated iron oxide nanoparticles can 
be seen in Figure 10. Copper nanoparticles have already been reported, such as zinc and iron 
nanoparticles, to be coated with silica [66].  In this work, the aim was to improve chemical 
stability of the nanoparticles, because during the storage period, the nanoparticles are unstable, 
leading to oxidation or aggregation, which represents an increase in particle size. To avoid both 
problems, the nanoparticles can be prepared in organic solvents, which minimize the surface 
oxidation. Nevertheless, organic solvents are hazardous and possibly very toxic to biological 
systems. Another strategy to prepare stable nanoparticles is the use of polymers or surfactants, 
which enable the interaction of oxygen atoms with the metal particles surface [72]. In addition, 
silica acts with a similar mechanism, creating a shell around the particle that prevents the 
contact of metal core with the outside, forming particles with a great stability in aqueous 
dispersions [66]. Copper nanoparticles with these coatings can be easily prepared by adding of 
a silica source, such as tetraethyl orthosilicate (TEOS), sodium silicate and (3-
aminopropyl)trimethoxysilane (APS) [64,66,70]. Often, the coating preparation requires the 
addition of two compounds containing silica, in a two-step production. The first step is the 
absorption, by the surface of metal nanoparticles, of the first silica compound added. The 
second step is the formation of the coating around the metal core. APS is commonly used 
during the first step to create this interface due to have amino group, which interact with metal 
particles easily [70]. In the second step, to obtain the silica coating is normally used either 
sodium silicate or TEOS that can be hydrolysed and condensed to allow the growth silica layer 
around the nanoparticle [66]. 
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Figure 10- TEM images of Fe3O4 nanoparticles (A). Fe3O4 nanoparticles coated with SiO2 (B) – 
Adapted from [71].   
 
 
Silica can also be used as a gel, where the nanoparticles can be encapsulated. 
Nanoparticle compounds in a solid matrix can be defined as nanocomposites [73]. Silica gel is 
commonly used, and easy to prepare in a three steps reaction, involving hydrolysis, 
condensation and polymerization. These reactions can be called sol-gel processing. 
Alkoxysilanes, such as APS, hydrolyse when present in water, forming an alcohol and a 
hydroxyl alkoxide containing silica, as seen in equation 1.  If the reaction is very extensive, i.e. 
till completion, all the alkoxy groups are replaced by hydroxyl groups, as represented in 
equation 2. Next, the condensation occurs, in which the hydroxyl alkoxides link together to 
form dimeric structures, and afterwards large polymeric structures (polymerization). Water or 
alcohol molecules form during the condensation and polymerization, as represented in 
equations 3 and 4 [74]. The oxo connections (Si-O-Si) between silicon atoms are responsible to 
form the gel matrix. Since Si(OH4) is considered to be the monomeric unit of silica polymer, 
the four hydroxyl groups can condensate with another molecules to form a branched polymer. 
As seen in equation 2, water is the limiting factor in the formation of a branched polymer, 
because in low water environments the formation of Si(OH4) is reduced, which leads to a 
reduction in branch degree, and consequently, in gel quality [74].  
 
A 
A B 
B 
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Sol gel processing reactions [74]: 
 
 
 
Different techniques can be applied using nanoparticles and silica gels. Pre-prepared 
nanoparticles can be fixed and/or modified inside the gel matrix, or synthesized inside the 
matrix [73]. To encapsulate, previously prepared nanoparticles, they can be added into a gel 
that is being formed. While the matrix is being polymerized, a three-dimensional network can 
be formed around the nanoparticles, which enables the use of nanoparticles, with desirable 
properties, directly in the matrix. A previous work showed that iron oxide nanoparticles can be 
impregnated in a silica matrix, preserving their properties [75]. However, sometimes the 
entrapment of unstable nanoparticles can cause changes in the properties of nanoparticles, such 
as agglomeration, which leads to particle size increasing. Also, the uniform dispersion of the 
particles in the gel is difficult to control. Such problems can be due to the increase in pH and 
ionic strength during the formation of gel [75]. Modification of the nanoparticles surface to 
create a stable interface, between particles and matrix, has been proposed to reduce the 
instability of nanoparticles [75]. Once again, silica coating demonstrated, that was effective to 
preserve nanoparticle properties, which were impregnated in a silica matrix. This matrix was 
prepared using two different silica sources: Sodium silicate and tetramethoxysilane (TMOS) 
[75]. Synthesis of nanoparticles within a silica matrix has also been proposed to overcome the 
difficulties associated with the fixation of already formed nanoparticles. It has the potential to 
produce nanoparticles without agglomeration and homogeneously distributed in the matrix. 
The synthesis can occur using the precursor of nanoparticles linked to the matrix, which will 
react to produce the nanoparticles, and organic functional groups have been reported to achieve 
this. These functional groups are able to create a link between the metal ions and silica matrix. 
For examples, the organic molecules may contain amino groups, which can chelate the metal 
cations and link them to the silica network. Then, the nanoparticles are obtained by degradation 
of the organic groups with controlled thermal treatment, as schematized in Figure 11. The 
thermal treatment involves very high temperatures (500°C) to degrade the organic groups and 
may also oxidize elemental nanoparticles, obtaining powders of their metal oxides. If the aim is 
not produce the metal oxide nanoparticles, it can be used hydrogen to reduce the metal oxides 
[73,76].  The nanoparticle size is directly influenced by the dispersion in gel, decreasing the 
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size distribution, with the increasing of the uniformity of dispersion [77]. The size distribution 
can be improved synthesizing the nanoparticles in a uniform matrix, where the growth of 
nanoparticles is controlled by the remaining space between polymeric branches. If the gel is 
uniform, the spaces are all similar, and consequently the growth of nanoparticles is limited, 
obtaining a narrow size distribution [76].  
 
 
 
Figure 11- Preparation of nanocomposites by sol-gel processing of organofunctional single-source 
precursors. The connected spheres represent the gel network formed from precursor A. In step 1, A are 
the silica precursor linked to B that is the metal source, for example a metal salt (~ is the organic group 
connecting A and B). In step 2, the sol-gel processing formed a gel, while the metal (B) kept attached to 
the matrix. In step 3, silica matrix was heated up and the organic groups that are linked to A and B were 
degraded, forming the nanoparticles [73].  
 
 
Zinc oxides have been already produced inside a silica matrix. Comparing with zinc 
oxides produced without the use of a silica matrix, the size changes were not significant. Also, 
the particles were highly uniformed dispersed. The stability of these particles was obtained by 
using a surfactant that stabilized the surface. The structure proposed for the ZnO and silica 
polymer is represented in Figure 12 [78]. 
  
Figure 12- Scheme of ZnO nanoparticles incorporated inside a silica matrix [78]. 
2 3 1 
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 Silica with metal nanoparticles has already been tested for antimicrobial purposes. 
Silver nanoparticles coated with silica were tested against some microorganisms in seawater, 
which are responsible for the corrosion of all material immersed in these environments. Silica-
coated nanoparticles showed to be very effective protecting the surface from oxidative 
microorganisms in water [79]. Also, the release of metal ions was tested during the exposition 
of seawater, showing that the amount of ions released is much lower than the released by the 
metallic materials commonly used, which can cause environmental problems, due to the high 
concentrations of metals generated after long times of exposition in water [79].  A different 
work, reported that copper-based nanoparticles, with 20 nm, were prepared in a silica matrix by 
production of a thin film under high temperatures. Both, copper and copper oxide nanoparticles 
were produced and tested against Escherichia coli. A solution containing these bacteria was 
spread in the silica film with copper nanoparticles and it was seen a great reduction of their 
viability [69]. Such results suggest that it is possible to apply copper nanoparticles, 
immobilized in silica matrixes, in surfaces, where the bacterial contamination has to be 
prevented, such as food packing or hospital surfaces. 
 
 
2.4. Analytical techniques for characterization of nanoparticles  
 
This section introduces some of the analytical techniques that could be used during a 
study of the development of copper nanoparticles with antibacterial activity. To study 
nanoparticles is important to characterize them, and Dynamic Light Scattering (DLS) can 
determine the size distribution of nanoparticles in a solution. Transmission Electronic 
Microscopy (TEM) is also useful not only for the particle size but also to obtain images that 
enable a better morphological characterization of nanoparticles such as possible agglomeration, 
coatings and shape. The Inductively Coupled Plasma- Optical Emission Spectrometry (ICP-
OES) is a very sensitive technique used in elemental speciation that is able to determine the 
concentrations of some elements such as copper down to ppb values. These will be the three 
main analytical techniques used in the experimental part of the project. 
 
2.4.1. Dynamic Light Scattering (DLS) 
 DLS is a technique to measure the particle size distribution of particles suspended in a 
solution. This technique measures the Brownian Motion, the random movement of particles in 
a solution, and establish a relation with the particle size because the increasing of the particle 
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size leads to a proportional decrease to the Brownian Movements, i.e. slower particles. The 
particles diameter is calculated from Stokes-Einstein equation: 
d (H) = (kT / 3  D)       
d (H) -  Hydrodynamic diameter 
D - Translational diffusion coefficient 
k - Boltzmann’s constant 
T – Temperature 
viscosity  
 This equation shows the relation between the hydrodynamic diameter and other 
physical parameters: Temperature, viscosity and translational diffusion coefficient. The last 
one is used to calculate the hydrodynamic diameter, so it is important that temperature and 
viscosity of the solutions are known and are constant during analysis, to obtain meaningful 
particle sizes. The speed of particles is obtained by measuring the different scattered light 
fluctuation rates of particles in solution. The scattered light is detected in the instrument and 
correlated to calculate the translational diffusion coefficient to obtain the particle size. The 
results are obtained in a graph representing the distribution sizes of the particles in solution. 
Figure 13 shows a graph representing the size distribution of an aqueous solution with 
nanoparticles. 
The DLS enables the measurement of nano-sized particles depending on the range of 
particles that is optimized to analyse. This nano-sizer allows the study of nanoparticle coatings, 
if these coatings influence the behaviour of the particle in solution. On the other hand if the 
particles are not spherical the correlation of particle size and the movement in solution is not 
the same and the obtained values could carry a bias [80,81].  
 
Figure 13- Size distribution by volume obtained using DLS for nanoparticles in aqueous system.  
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2.4.2.  Inductively Coupled Plasma - Optical Emission Spectrometry (ICP-OES) 
 The ICP-OES is an analytical technique developed to identify and quantify elements in 
different chemistry systems. The ICP-OES is characterized by a plasma source which is 
responsible for atomization of samples. The plasma can be defined as a gas electrically neutral 
composed by ions, electrons and atoms, whose temperature is incredibly high and can reach 
values near the temperature on the sun’s surface, 8000K. In ICP-OES analysis the sample is 
pumped into the instrument, where the sample will be nebulised. Next, the water is removed 
and the sample is atomized in the torch, where the atoms become excited, emitting light of a 
characteristic wavelength. The ICP torch is composed by a plasma flame generated by a flow 
of argon. This light will be detected and measured in the spectrometer, to obtain the 
concentrations of each element. A scheme of an ICP-OES analyser is represented in Figure 14.  
During this project this technique can be used to quantify copper with a great sensitivity, range 
of ppb. 
 The limitations of this technique could be related with the emission at same wavelength 
of different elements. Also the formation of different species for the same element, such as 
different ions and neutral species that have different emissions could be a problem in analysis 
[82].  
 
 
Figure 14- Schematic of the composition of an ICP-OES analyser [108]1. 
                                               
1 Image adapted from http://www.aandb.com.tw/Page0001/icp_oes_01_optima_7x00_dv.html  
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2.4.3.  Transmission Electron Microscopy (TEM) 
 TEM is a microscopic technique with great definition that consists in an electron beam 
crossing through an ultra-thin sample that is processed to obtain the image. Information about 
the chemical composition, morphology and structure is obtained through the variety of signals 
that result from the interaction between electron beam and specimen. As the electrons pass 
through the specimen, the sample has to be very thin. The maximal thickness can be obtained 
increasing the acceleration voltage and decreasing the atomic number of the atoms in the 
sample [30]. The electron microscopy was developed to overcome the limited resolution of 
light microscopy, due to the wavelength of visible light. The detection limit of TEM leads to 
their use in nanotechnology because it allows the characterization of nano-sized material. 
Shape, particle size, agglomeration and surface modifications can be observed in TEM images. 
This technique is able to analyse either solid or liquid samples, such as suspensions, and 
requires a very small amount. Some figures showed above in this monograph were obtained by 
TEM (Figure 7, 10, 22 and 32).  
The limitations of this technique can be related with the difficult preparation of some 
samples, especially due to the thinness required. Often the sample can also be altered during 
the analysis. The high cost involved not only in equipment but also in sampling could limit 
their use. Finally the detection limit sometimes is not enough to observe very small structures 
[83]. 
 
 
2.4.4. X-Ray Diffraction  
X-ray diffraction is a technique used to identify materials, in particular crystalline 
substances. X-ray diffraction analysis considers that the materials can be characterized in two 
forms, crystalline or amorphous, which are distinguished by the order of their structures. A 
crystal is composed by an ordered structure, with its atoms arranged in a regular pattern that 
may be a repetition of a smaller unit, whereas an amorphous compound presents a disordered 
structure, with atoms distributed randomly. X-ray diffraction consists in the analysis of a 
diffraction pattern that is obtained by incidence of an x-ray beam through a crystal that diffracts 
the beam in many directions. The different angles of diffraction and corresponding intensities 
can be detected to determine the atomic structures present in the crystal. For different crystals 
are obtained different diffraction patterns, which means that can be used as a “fingerprint” of a 
substance. This method is only possible due to the X-rays have a wavelength in the order of 1 
Angstrom (0.1 nm), which is in the same order of the size of an atom [84].  
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Braggs’s law can explain this phenomenon of interference pattern of X-rays scattered 
by crystal (Figure 15), and is represented by the following equation: 
  
Bragg’s Law:  nλ= 2d sin θ 
 
λ – Wavelength of the x-ray beam 
θ – Incident angle  
d – Distance between atomic layers in a crystal 
n – Order of the diffraction peak (integer number) 
 
Bragg’s law establishes a relationship between an X-ray beam with a specific 
wavelength (λ), the refracted angle (θ), and the distance between atomic plans (d). The 
wavelength is known and the angle θ can be determined experimentally, which allows the 
calculation of the distance between atomic layers (d). the interpretation of the calculated d 
values should allow the identification of materials by comparison and matching with standard 
reference patterns, once each compound presents a unique patterns. 
 
 
Figure 15 – Schematic of an incident X-ray beam being diffracted by the atoms present in the different 
layers of the crystal2.  
 
 
In particular, the method used was X-ray powder diffraction, to identify crystalline 
solids. The results are normally analysed in a diffractogram representing the diffracted 
intensity as a function of angle 2θ, that is obtained during the scan of the sample and the peaks 
                                               
2 Image obtained from http://tap.iop.org/atoms/xray/530/page_47297.html 
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detected correspond to the angles in which the X-ray beam were diffracted by the crystal. This 
method can be used not only to determine mineral structure of compounds, but also is able to 
determine the degree of crystallinity [85].  
In conclusion, X-ray powder diffraction should be able to identify the materials 
synthesized, even if there is a multiplicity of components in a mixture. Also, sample 
preparation is easy and the analysis is very quickly. 
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3. Material and Methods 
 
3.1. Materials  
 
Chemical Compound Chemical Formula Supplier 
Copper (II) Chloride di-hydrate CuCl2.2H2O Sigma  
L-Tartaric acid C4H6O6 Sigma 
Adipic acid C6H10O4 Sigma 
Citric acid C6H8O7 Sigma 
Malic acid C4H6O5  Sigma 
Sodium Hydroxide  NaOH Sigma 
Iso-sensitest broth CM 0473 Not applicable Oxoid 
Iso-sensitest agar CM 0471 Not applicable Oxoid  
Sodium silicate solution SiO2.NaOH Sigma 
 
 
3.2. Methods 
3.2.1. Copper hydroxides ligand-modified nanoparticles synthesis 
Cu(OH)2, Cu(OH)2Ad, Cu(OH)2Mal, Cu(OH)2Cit, Cu(OH)2Tart and Cu(OH)2Tart-Ad 
were prepared from copper chloride as described in patent WO/2008/096130. Cu(OH)2Tart-Ad 
nanoparticles synthesized were dried at 45°C overnight and then resuspended into the same 
mass of water to obtain initial concentration.  
3.2.1.1.  Identification of synthetic materials 
The materials synthesized were completely dried at 45ºC and the powders were milled 
and analysed by X-Ray Diffraction at the Earth and Environmental Department at the 
University of Leeds.  
3.2.1.2.  Copper hydroxide ligand-modified nanoparticles in broth:  
The copper nanoparticles suspension prepared previously and the dried and 
resuspended solution of copper nanoparticles were diluted in broth on a range of concentrations 
between 1 and 100 ppm. Then, the samples were analysed by ICP-OES (JY2000, Horiba Jobin 
Yvon). Particles size analysis was not carried out, due to the low concentration of nanoparticles 
which is below to their detection limit. 
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3.2.2. Nanoparticles modifications 
3.2.2.1.  Heat treatment 
An attempt to synthesize copper oxide nanoparticles was carried out from copper 
chloride as described in patent WO/2008/096130. This synthesis took place under a boiling 
solution, closer to 100°C. Tartaric acid and adipic acid were used as ligands. 
3.2.2.2.  Silicon modified copper hydroxide nanoparticles  
The procedure was the same as used in the synthesis of copper hydroxide ligand-
modified nanoparticles (3.2.1). The sodium silicate solution with a concentration of 10, 20, 30 
and 40 mM of silicon was added into the solution containing copper chloride and the ligands 
which were then titrated with NaOH 5M. The silicon modified copper hydroxide nanoparticles 
were diluted in broth on a range of concentrations between 1 and 100ppm of copper. 
 
3.3. Entrapment of nanoparticles in a silica gel matrix 
Cu(OH)2Tart-Ad were prepared from copper chloride as described in patent 
WO/2008/096130. Instead of use sodium hydroxide, was used a concentrated solution of 
sodium silicate (7M). The final gel with copper was dried to be analysed by TEM.  
 
3.4. Antibacterial activity of different copper hydroxide nanoparticles synthesized 
3.4.1.  Copper stock suspensions 
Copper suspensions with concentrations of 1, 10 and 100 ppm were prepared in broth 
by diluting the original copper nanoparticle suspension. The suspensions were filtered through 
a 0.2 m membrane to sterilize the solution.   
3.4.2. Preparation of broth and agar media 
The broth solution was prepared in ultrapure water and then autoclaved at 121°C during 
15 minutes. Agar plates were prepared to assess a possible contamination of E.coli culture. The 
agar medium was prepared in ultrapure water and then autoclaved. Next, the solution was 
cooled down to 50°C and distributed in sterile petri dishes to form the agar gel. The agar plates 
were kept on fridge upside down.  
3.4.3. Determination of antibacterial activity 
To determine the amount of bacteria in solution was used a turbidimetric assay for 
quantitation of viable bacterial density, using Escherichia coli NCTC11100. Bacterial cells 
present a higher refractive index than water, thus scattering incident light, which can be 
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measured using a visible wavelength. The bacteria cultures were prepared in the day before to 
grow overnight at 37°C with shaking. Different decimal dilutions of bacterial culture were 
prepared in a sterile 96 well-plate and the optical density was measured at 595 nm using a plate 
reader (Multiskan RC 351, Labsystems). The same concentrations of bacteria were used for 
each concentration of copper tested in the sterile 96 well-plate. The plate was kept at 37°C with 
shaking and the measurements were carried out at 0, 2, 4 and 6 hours after prepared the plate. 
 To every sample the blank was corrected, by subtraction of the baseline (without 
bacteria) to every well on the correspondent row in the 96 well-plate.  
3.5. Copper phase distribution analysis: 
All the samples were diluted in 5% nitric acid to dissolve completely the copper and 
then analysed by ICP-OES, using a wavelength of 324.754 nm. Different standard calibrations 
were used, with copper concentrations ranging between 0 and 150 ppm. To study the fractions 
of copper, i.e. soluble, nanoparticulated and precipitated, three aliquots were collected for each 
pH. One aliquot was used to calculate the total copper in solution, a second one was 
centrifuged and the supernatant was analysed and the last sample was ultrafiltered through a 
membrane of 3KDa and then analysed to determine the soluble copper. The calculations used 
were: 
Copper Precipitated % :  [(Cutotal – Cusupernatant)/ Cutotal ] * 100 
Copper Soluble % :    (Cusoluble / Cutotal) *100 
Copper Nanoparticulated %  100 – Cusoluble (%) – Cuprecipitated (%) 
 
3.6. Particle Size analysis: 
Dynamic Light Scattering (DLS) (Zetasizer, Malvern Instruments) was used to obtain 
the particle sizes distribution. A 0.5 ml sample was transferred to a cuvette to be analysed. All 
the samples were analysed in DLS immediately after have been prepared. The error bars shown 
in the particles size distribution were obtained from 3 measurements.  
 
3.7. Transmission Electron Microscopy analysis 
TEM analysis was carried out by Dr. Emma Thomas-McKay at the Multi Imaging Centre 
of the Department of Physiology, Development and Neuroscience at The University of 
Cambridge. 
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4. Results and Discussion 
4.1. Copper hydroxides nanoparticles synthesis 
The first part of this work consisted in the synthesis of nanoparticulated copper materials, 
in which different ligands were tested in the synthesis of copper hydroxide nanoparticles. Also, 
the materials were characterized by Dynamic Light Scattering (DLS), to obtain the size 
distribution of particles in suspension, and by ICP to determine the copper phase distribution3, 
with a particular interest in the percentage of nanoparticulated copper.  
Copper is a hydrolytic metal, that forms ions in aqueous solution that act as a Lewis, i.e. 
receive electrons from the solution decreasing its pH (Equation 5 and 6). Thus, when copper 
chloride was dissolved in water, the final pH was below 2. The addition of sodium hydroxide 
into the copper solution increased the pH and, above pH 4 copper started precipitating, as seen 
in the Figure 16. The precipitation seen was due to the formation of copper hydroxide that was 
not soluble (Equation 7). The overall reaction of copper hydroxide synthesis in aqueous 
solution may be explained by the Equation 8. This reaction was the basis of the copper 
nanoparticles formulation and the control of this agglomeration of copper hydroxides can lead 
to the synthesis of the respective nanoparticles. 
 
Equations: 
CuCl2.2H20 (s)→Cu2+(aq) + 2Cl-(aq) + 2H20 (l)   (5) 
Cu(H20)n2+ + H20 → Cu(H20)n-1(OH)1+  + H30+  (6) 
Cu2+(aq) + 2OH- (aq) → Cu(OH)2 (s)   (7) 
CuCl2.2H2O + 2NaOH → Cu(OH)2 + 2NaCl + 2H2O (8) 
 
 
Figure 16- Copper precipitation curve at different pHs.   
                                               
3 Copper phase distribution refers to the differences between soluble, nanoparticulated and precipitated copper and 
not mineral phases of this compound. 
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The synthesis of copper hydroxide nanoparticles in the current work consists in mixing 
copper ions and organic ligands at a low pH and then increase to a higher pH, using a strong 
alkaline solution, such as sodium hydroxide, to cause the solid precipitate of solid-ligand 
modified copper ions materials. The manipulation of ratio, initial and final pH and the rate of 
change between the initial and final pH are essential for the formation of nanoparticles. The 
starting pH should be below the polymerisation pH of copper, between pH 3 and 4, also the 
final pH should be above this range of pH to produce solid copper hydroxides. Malic acid and 
citric acid were tested in the formulation of copper hydroxide nanoparticles as they are 
protonated at low pH and have the potential to be incorporated into the solid phase of the 
ligand modified materials. 
Malic acid is a dicarboxylic acid that is deprotonated (malate) in aqueous solution at 
physiological pH, and consequently, becomes negatively charged. It is present fruits, such as 
apples and it is used as a chelating agent in magnesium supplements. Malic acid is not only 
able to transport this mineral to different tissues, especially brain, but also to bind aluminium to 
be excreted out of the organism, preventing its accumulation in the tissues [86]. The use of this 
organic acid in the synthesis of copper-based nanoparticles resulted in  the production of 
nanoparticulated copper in low amounts, only 30% at pH 7, as seen in Figure 17A.  These 
experiment indicates that possibly malic acid is a strong chelator that keeps the metals bound in 
solution, being inadequate for the synthesis of nanoparticles, as showed the high soluble 
fraction of copper obtained even at higher pH. The particle size distribution of copper 
hydroxides nanoparticles synthesized with malic acid showed particles around 30 nm, as seen 
in Figure 17B.  
Citric acid is a tricarboxylic acid that is also deprotonated in aqueous solution (citrate) 
at physiological pH. This molecule can be used as a chelating agent to keep metals in aqueous 
solution, and it is also very important in the human metabolism, therefore should not present 
safety issues. The addition of citric acid showed again that nanoparticulated copper was 
synthesized as seen in Figure 18A. Also, copper was not completely soluble, at higher pH, 
being mostly nanoparticulated, especially above pH 6. At pH 8, about 63% of the copper was 
nanoparticulated, but the particle size analysis showed that most of these nanoparticles were 
not stable and possibly agglomerated quickly, being detected only very large microparticles 
(Figure 18B). DLS is not appropriate for the analysis of large particles, and great error bars 
were determined due to sedimenting particles which are known to affect the measurements. 
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Figure 17- Copper phase distribution as a function of pH (A) and particle size distribution of 
Cu(OH)2Mal (B). 
 
Figure 18- Copper phase distribution as a function of pH (A) and particle size distribution of 
Cu(OH)2Cit (B). 
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The results using malic acid showed that only 30 % of the total copper was 
nanoparticulated, which was too low yield of nanoparticles production. The use of citric acid 
improved the amount of nanoparticles obtained to 70%, but in the particles size distribution 
were detected only large particles, probably due to the quickly agglomeration of smaller 
nanoparticles. Thus, the following step was to test a different ligand, and tartaric acid was used 
using the same procedure as used previously. The synthesis with this ligand improved the 
amount of nanoparticulated copper to 70% of the total copper, and reduced the precipitated 
copper (Figure 19A), comparing with the synthesis using malic acid and citric acid. Also, an 
improvement in particle size distribution was seen, in which were detected very small 
nanoparticles of 1 nm with a narrow distribution, which means that the size of the particles did 
not present a great variation (Figure 19B). Although the improvement in the amount of 
nanoparticulated copper and also in particle size in the synthesis of nanoparticles using tartaric 
acid, the amount of copper soluble was still higher than 20%, and the pH was difficult to 
control during the experiment, due to the low buffer capacity of the solution. For that reason, 
adipic acid was added to improve the buffer capacity of the solution.    
 
 
Figure 19- Copper phase distribution as a function of pH (A) and particle size distribution of 
Cu(OH)2Tart (B). 
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Tartaric acid and adipic acid were then used as ligands, which led to the production of 
copper nanoparticles, as already expected (Figure 20). Comparing with the experiment using 
only tartaric acid, the amount of nanoparticulated copper increased from pH 5 till pH 8, where 
it reached more than 90% of the total copper. Also, the precipitation at higher pH was reduced. 
A peak of precipitation was observed at pH 4, which may be due to the beginning of the 
formation of copper hydroxides that were not soluble. Although there was a continuous 
formation of copper hydroxide during the titration, copper hydroxides nanoparticles were 
formed above pH 4 only. Tartaric acid was the main responsible to the formation of copper 
hydroxide nanoparticles, because the same experiment using, only adipic acid, showed that 
there was any formation of nanoparticulated copper, more than 99% was precipitated copper. 
The higher interaction between copper and tartaric acid may increase the repulsion between 
particles, especially when tartaric acid was charged (tartarate). Its pKa2 is 4.25, which leads us 
to believe that can be associated to the formation of nanoparticles observed above pH 4. The 
pH influenced the amount of nanoparticles obtained and also their size. At pH 7 the 
nanoparticles were larger (~70 nm) than at pH 8 (3-4 nm). This decrease in particle size may be 
explained by the disaggregation that occurred after the precipitation of copper. An evidence of 
the end of the disaggregation process can be seen in the Figure 21A where the size of 
nanoparticles was reducing with the increasing of pH. Drying and resuspending the copper 
nanoparticles suspension did not modify the size of nanoparticles obtained, as seen in Figure 
21 B and C. Also, the peaks obtained were narrow, which means that the population of 
nanoparticles is can be well defined by size. The nanoparticle size and the narrow size 
distribution obtained by DLS at pH 8 can be confirmed in the TEM images, Figure 22, where 
the particles were very small, well-dispersed and seemed to present a very similar size between 
them.  
 
Figure 20- Copper phase distribution of Cu(OH)2Tart-Ad. 
0%
20%
40%
60%
80%
100%
1 2 3 4 5 6 7 8
Co
pp
er
 p
ha
se
 d
is
tr
ib
ut
io
n
pH
Soluble %
Nano %
Precip. %
55 
 
Comparing with the previous experiment, using only tartaric acid, great improvements 
were obtained, such as high nanoparticulated copper at physiological pH (6-8), and 
consequently a reduction in precipitated and soluble copper, was also obtained narrow sizes 
distribution of nanoparticles. Thus, the effect of adipic acid may be due to the increase of 
buffer capacity that increased the amount of NaOH added during the titration to reach the same 
pH, which lead to the production of nanoparticulated copper, decreasing the solubility.  
 
 
 
 
Figure 21- Particle size distribution of copper nanoparticles synthesized using the ligands tartaric acid 
and adipic acid, Cu(OH)2Tart-Ad, A) as a function of pH; B) at pH 8.2 and C) pH 8.2 dried and 
resuspended nanoparticles. 
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Figure 22- TEM image of copper hydroxide nanoparticles, Cu(OH)2Tart-Ad (scale 20 nm). 
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4.1.1. Identification of synthetic materials  
The identification and characterization of synthesized materials was carried out by X-
Ray Diffraction (XRD), to determine the mineral phase of copper materials synthesized, in 
particular the precipitated materials obtained from the mixture of copper chloride with sodium 
hydroxide and Cu(OH)2Tart-Ad nanoparticles synthesized. This method is able to provide a 
pattern of a crystalline material which is a “fingerprint” of the substance.  
The copper mineral phase detected by XRD and shown in Figure 23A was 
paratacamite. This mineral phase is one of the four possible polymorphs of copper hydroxides 
with chloride incorporated(Cu2(OH)3Cl) and is composed of two simple copper salts, copper 
chloride (CuCl2) and copper hydroxide (Cu(OH)2) in a ratio of 1:3, respectively [87]. 
Paratacamite presents a rhombohedral crystalline structure with a pale green colour and is the 
most stable phase of the Cu2(OH)3Cl forms, which means that normally other polymorphs, 
easily tend to recrystallize to form paratacamite [88]. The synthesis of paratacamite was easily 
carried out by direct precipitation, when sodium hydroxide was added to an aqueous copper 
chloride solution, and this procedure has been reported as allowing the synthesis of pure 
paratacamite [89]. Nevertheless, different copper hydroxides can be prepared using the same 
protocol, only by manipulating the initial concentrations of copper and the ratio of copper, 
chloride and hydroxide. Paratacamite was reported to be obtained when CuCl2 and NaOH were 
mixed in the same ratios and the mixture was independent of the order of addition [90]. 
Furthermore, to obtain only solid copper hydroxide (Cu(OH)2) the hydroxyl ions (OH-) should 
be present in excess, and this reaction produces a blue precipitate, typical of spertiniite, 
contrasting with the green colour of paratacamite [88,89].  
The Figure 23B shows the XRD spectrum of Cu(OH)2Tart-Ad nanoparticles, being this 
method inconclusive to determine the mineral phase, due to the high amorphous phase 
detected. The two peaks represented in the spectrum at position 2θ32° and 46° corresponded 
to halite, a crystal constituted of sodium chloride that was present during the synthesis4. As 
seen above, in the absence of ligands, the mineral phase formed was a copper hydroxide with 
chloride incorporated, and consequently, the nanocrystalline copper hydroxides synthesized 
could also be paratacamite.  
The characterization of mineral phase of copper hydroxides nanoparticles synthesized 
showed an amorphous phase at micro-scale. The characterization of a possible crystalline 
nanomaterial, as suggested by TEM, would require electron diffraction of High Resolution 
                                               
4 Information obtained in the data report from the University of Leeds. 
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Transmission Electron Microscopy (HRTEM) where the phase of individual small 
nanoparticles can be determined5. 
 
 
 
Figure 23- XRD characterization of copper hydroxides particles synthesized by direct addition of 
Sodium hydroxide into a solution of copper chloride (A) and Cu(OH)2Tart-Ad nanoparticles (B).  
 
  
                                               
5 Personal communication by Dr. Andrew Brown from the Institute of Materials Research, University of Leeds 
A 
B 
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4.1.2. Copper phase distribution analysis in broth 
The aim of this experiment was to characterize the copper phase distribution in broth, 
which was the medium used in the antibacterial assays. The results showed that most of the 
copper was soluble in the different concentrations tested, as seen in Figure 24, which may 
mean that copper hydroxide nanoparticles were very labile, dissolving easily at lower 
concentrations. Another possible explanation is that these were due to an analytical artefact. As 
smaller the nanoparticles may be able to cross through the 1.9 nm (3KDa) pore diameter filter 
being detected as copper soluble, which would justify the obtained results. Increasing the 
concentration of copper in broth was also showed to decrease the amount of nanoparticulated 
copper. This finding was not very well understood as the opposite was expected, i.e. an 
increase in nanoparticulated copper fraction with the increase of copper concentration, as seen 
in a previous experiment carried out by Tin Wong at MRC-HNR laboratory, in which the 
nanoparticles were dissolved in water, using the same concentrations (data not shown).  
 
 
Figure 24- Copper phase distribution at different concentrations of copper in broth. A) Copper 
nanoparticles solution prepared with the described method. B) The same solution, but dried and 
resuspended. The errors bars are standard deviations of 2 independent replicates.  
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4.2.  Nanoparticles modifications 
The solubilisation of copper hydroxide nanoparticles in broth may have been an analytical 
artefact, but also the nanoparticles possibly were not very stable at low concentrations in 
complex environments. Thus various strategies were tested to develop more stable copper-
based nanoparticles. 
  
4.2.1.  Heat treatment 
The synthesis of copper oxide nanoparticles (CuO) was attempted since these 
nanoparticles should be more stable than the previously synthesized copper hydroxides 
nanoparticles [55]. Copper oxides can be prepared from copper hydroxides by heating, thus 
boiling conditions should be able to provide the ideal conditions for the synthesis of copper 
oxides. The equations shown below represent the proposed reactions of formation of copper 
hydroxide (9), and its conversion in copper oxide under high temperatures (10). The equation 
11 represents the overall reaction.  
 
Equations: 
CuCl2.2H2O + 2NaOH → Cu(OH)2 + 2NaCl + 2H2O (9) 
Cu(OH)2 Heat> CuO + H2O     (10)  
CuCl2.2H2O + 2NaOH  Heat>  CuO + 2NaCl + 3H2O   (11) 
 
The synthesis was attempted by repeating the same method used to synthesize the 
copper hydroxides nanoparticles, but at boiling temperature (~100ºC). During the experimental 
work was obtained a green boiling solution, which contrasted with the blue suspension of 
copper hydroxide nanoparticles synthesized previously, which indicates that probably was 
formed a different copper phase. However, after centrifugation a green precipitate at the bottom 
of the tube was seen, and the supernatant was blue. In spite of the presence of a precipitate, the 
amount of copper nanoparticles obtained was higher than 50%, as seen in Figure 25A. The 
nanoparticles presented a size between 10 and 30 nm at pH 7, as seen in Figure 25B. The 
precipitated copper was 40% of the total copper and may correspond to agglomeration caused 
by the heat treatment [55].  
In this experiment the pH was difficult to control, due to the low buffer capacity of the 
solution. Finally, the synthesis was carried out again with same amount of copper and tartaric 
acid, but in the presence of adipic acid, which increased the buffer capacity of the solution, 
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allowing a better control of pH. Also, adipic acid is a weak ligand that can bind copper to 
prevent the precipitation seen in the Figure 25A.  
 
 
 
Figure 25- Synthesis of CuOx(OH)y-Tart at boiling temperature; A) Copper phase distribution during 
the titration. B) Particles size distribution obtained at pH 7 (centrifuged before analysis).  
 
The results shown in Figure 26A confirmed the initial expectations using adipic acid, the 
precipitated copper fraction decreased comparing with the synthesis of CuOx(OH)y-Tart 
(Figure 25A), also the soluble copper decreased, and consequently the nanoparticulated 
fraction at pH 8 was higher (73%). The particle size distribution at pH 8 showed nanoparticles 
mostly of 3-4 nm (Figure 26B), which were of similar size to the Cu(OH)2Tart-Ad 
nanoparticles synthesized, as shown in Figure 21B, but the comparing with the copper phase 
distribution (Figure 20) the amount of copper nanoparticulated was still below the target level, 
i.e. above 90%.  
 The highest amount of nanoparticulated copper obtained was 70% only, which was too 
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nanoparticles were not synthesized, such as the blue colour of the suspension and the size of 
the nanoparticles synthesized were very similar to the copper hydroxides synthesized. The 
main difference of the synthesis at boiling temperature was the green precipitate obtained, 
which may be a copper oxide chloride, due to the excess of chloride in solution which can be 
incorporated inside the structure [87]. Also, the greenish colour is coincident with the colour 
described for copper oxide chloride compounds, and differs to copper (II) oxide (CuO), which 
is a black compound. The characterization and identification of this compound may be done by 
XRD.  
The method used was not ideal for the synthesis of copper oxide nanoparticles and 
further approaches might be done in the future to improve the amount of nanoparticulated 
copper. Then, the characterization of the synthesized compounds and the analysis of copper 
distribution phase in broth should be done to identify the copper mineral phase of nanoparticles 
synthesized and also to test the dissolution in broth.   
 
 
 
Figure 26- Synthesis of CuOx(OH)y-Tart-Ad at boiling temperature; A) Copper phase distribution as a 
function of pH. B) Particles size distribution obtained at pH 8 (centrifuged before analysis).  
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4.2.2. Silicon modified copper nanoparticles 
Silicate was added into the copper solution to prepare copper nanoparticles with silica 
incorporated or creating a layer around copper nanoparticles, to form a protective shell, to 
protect nanoparticles against environmental instability factors, as reported to be able to protect 
elemental copper nanoparticles to be oxidized [1]. Also, the high affinity of silica for metals 
allows their easy interaction and consequently easy complexation [2]. Furthermore, this 
modification would be able to lead to more stable nanoparticles, avoiding problems such as 
high solubility in broth. Sodium silicate was used as the silicon source in this experiments, as it 
had been previously used in synthesis of nanoparticles for antimicrobial applications [5,6]. This 
sodium salt of silicic acid presents an alkaline character, being more soluble above pH 9, due to 
the formation of silicate ions [91]. Silicate was used in low concentrations to avoid 
polymerization and consequent formation of silica gel. In the presence of silicate, copper were 
mostly in a nanoparticulated phase, especially at lower concentrations of silicate, such as 10, 
20 and 30mM (Figure 27). At 30mM precipitated copper increased, indicating that larger 
particles were forming, and similarly at 40mM, 60% of the copper was precipitated. This result 
showed that the presence of silica influenced the formation of copper hydroxide nanoparticles, 
which may be explained due to copper complexation with silica forming large particles that 
agglomerate. Alternatively, silica polymerization may be responsible, since pH was kept in 
range of pH which silica is highly insoluble. At higher concentrations of silica, the particles 
growth is faster, probably by polymerization of monomeric species, and precipitates quickly 
attaching some copper [92]. Furthermore, the particle size distribution showed very large 
particles (Figure 28D), which were micron sized, and consequently, large enough to 
precipitate, confirming the copper phase distribution. At lower concentrations of silicon, the 
precipitated copper was very low or even inexistent (20mM), which supported the theory of 
growth of silica polymers. At these concentrations the copper was present as a nanoparticulated 
phase (>90% of the total copper) and characterization by DLS showed that the size was 
dependent on the silicon concentration used, as seen in Figure 28 and Figure 29. Furthermore, 
at higher concentrations the particle size showed large error bars, which may be explained by 
sedimenting particles present in suspension, which reduced the accuracy of measurement, 
especially at 30mM and 40mM, Figure 28C and D respectively.  
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Figure 27- Copper phase distribution of Cu(OH)2Tart-Ad nanoparticles prepared in the presence of 
different concentrations of sodium silicate.  
 
 
Silica showed to influence the nanoparticles synthesized, this may have been due to 
silica incorporation into the copper hydroxide nanoparticles which is supported by the increase 
in particle size with the increasing in silica concentrations. Alternatively, silica may have 
formed a coating around copper hydroxide nanoparticles, an increase in silica led to an increase 
in the thickness of the coating. Further analysis must be done in order to understand the role of 
silica in this synthesis. TEM and XRD would be two techniques to identify and characterize the 
nanoparticles synthesized. The TEM could be a good tool to analyse the formation of a coating 
around the nanoparticles, and to compare how the different silicon concentrations affected the 
size of nanoparticles. The XRD would be able to identify the mineral phase present, and maybe 
indicate if silica changed the mineral phase of copper nanoparticles.  
The nanoparticles synthesized in the presence of 10mM, 20mM and 30mM of silica, 
were tested in broth at low concentrations of copper in broth to investigate if there was any 
influence the solubility of copper. The synthesis using 40mM of silicon was not tested due to 
low amount of copper nanoparticulated, only 29%, as seen on Figure 27. 
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Figure 28- Particle size distribution of Cu(OH)2Tart-Ad particles prepared in the presence of sodium 
silicate  with different concentration of silicon: a) 10mM, b)20mM, c) 30mM and d) 40mM.  
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Figure 29- Particle size as a function of silicon concentration in the preparation of Cu(OH)2Tart-Ad. 
The error bars are standard deviations of 3 measurements.  
 
 
4.2.2.1. Silicon modified copper nanoparticles in broth 
The presence of silicate during the synthesis of nanoparticles did not result in 
significant differences in the solubility of copper in broth, especially at 10mM and 30mM of 
silicate, as seen in Figure 30A and C. An increase in nanoparticulated copper was seen in the 
graph of 20mM of silica (Figure 30B). The solubility of copper in the presence of silicate may 
lead to wonder whether copper nanoparticles were not modified by silicate, or if the 
modification produced was not able to reduce the high lability of nanoparticles, and 
consequently their solubilisation. The hypothesis of copper nanoparticles were not modified by 
silicate was not supported by showed above that showed the increasing of particles size, with 
the increasing of silicate concentration. Although the influence of silicate is not understood 
using the analysis carried out so far, the silicate seemed to have an influence in copper 
nanoparticles. On the other hand, this possible modification did not show influence in the 
solubility of copper nanoparticles. Also, there was no correlation between copper solubility in 
broth and the concentration of silica. 
Once again, as already seen above, the nanoparticulated copper tends to decrease with 
the increasing of copper concentration, especially it can be seen at lower concentrations of 
silica used, Figure 30A and B.  
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Figure 30- Copper phase distribution of Cu(OH)2Tart-Ad nanoparticles synthesized in the presence of 
a)10mM, b)20mM and c)30mM of sodium silicate. 
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4.3. Entrapment of nanoparticles in a silica gel matrix 
The entrapment of nanoparticles inside a silica gel matrix was developed in parallel to 
the synthesis of disperse nanoparticle suspension. This strategy was of interest because it 
allows the direct utilization of antimicrobial activity of copper nanoparticles in a matrix, to 
apply, for example, in covering of surfaces or in food packaging. Also, some studies reported 
the use of gel, such as silicon gels, as template for the synthesis of nanoparticles, because the 
growth of nanoparticles can be controlled by the pores size in the gel. The result of this 
synthesis showed that can be obtained nanoparticles without agglomeration, presenting a 
narrow size distribution [85].  Sodium silicate (SiO2.NaOH) was used as silica source for the 
production of gel, and its gradual addition provided hydroxyl groups into solution that could be 
able to form copper hydroxides, which in the presence of ligands such tartaric acid and adipic 
acid can form nanoparticles as explained above in the synthesis of Cu(OH)2Tart-Ad 
nanoparticles (section 4.1). Meanwhile, the concentration of silica was increasing and 
consequently the solution started to polymerize over the titration. In the end it was expected to 
obtain copper hydroxides nanoparticles, inside the matrix of the silica gel. To investigate that 
was determined the amount of copper that was present in the gel.  
Experimentally, the gel formed was blue, probably meaning that some copper was 
entrapped in the matrix, which can be confirmed in the results obtained, shown in the Figure 
31. Above pH 6 can be seen an increasing in copper precipitated, that probably is due to the 
formation of gel at this pH, as seen experimentally. The titration with sodium silicate was 
stopped at pH 7, and after one hour, the amount of copper in supernatant and in gel was the 
same, as seen in Figure 31. This result led to believe that polymerization of silica occurred 
quickly during the addition of silica into solution, and ended when the addition stopped. Also, 
copper was not released in the supernatant after stopped the polymerization.  
At pH 7, 75% of the copper was fixed in the gel, but was important to know if the 
copper was nanoparticulated. The procedure to determine the copper phase distribution 
required ultrafiltration that was not possible with the gel. Although this problem, the copper in 
supernatant was analysed, showing that 66% of the copper was precipitated (Table 5). The 
proposed reason for that result was the presence of small particles of silica polymerized with 
copper attached that precipitated after centrifugation, which mat occurred because of the great 
affinity of copper and silica [93]. Although this precipitation observed, there was 34% of 
nanoparticulated copper in supernatant, which was an indication that during this method some 
nanoparticles can be produced, and probably the copper inside the gel may be nanoparticulated. 
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Thus, the investigation of the presence of copper entrapped in the gel was carried out by TEM, 
confirming that copper was nanoparticulated in gel, as shown Figure 32. 
 Cu(OH)2Tart-Ad nanoparticles can be encapsulated inside a gel of silica, but to apply 
this new synthesized material the antimicrobial activity of copper should be tested. The method 
described above was used for copper in liquid environments, and obviously was not adequate 
to test a gel. Thus it is required the development of a method to assess the antimicrobial 
activity of copper hydroxides nanoparticles that are entrapped in the solution to evaluate the 
potential of this material.  
 
  
  
Figure 31- Percentage of copper retained in the gel as a function of pH (A) and then, the same gel with 
copper over the time (B). 
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Table 5- Copper phase distribution in supernatant of gel.  
 
 
 
 
 
 
 
Figure 32- TEM image of Cu(OH)2Tart-Ad  nanoparticles encapsulated inside a gel of silica. 
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Precip. % 
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Nano % 
66.04 0.00 33.96 
Cu(OH)2-Tart-Ad 
nanoparticle 
(<5nm) 
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4.4.  Determination of antibacterial activity 
The antimicrobial assay method was developed to analyse the antibacterial activity of 
different metal compounds, whether ionic or nanoparticulated. This method was developed to 
compare the inhibition of different antimicrobial compounds with a normal bacterial growth. 
Thus, this is not a method to count Colony Forming Units (CFU) as used in most of the 
traditional microbiological assays. The bacterial counting was done by measurement of optical 
density (OD) at 595nm, which can provide a direct correlation with the bacterial concentration, 
as seen in Figure 33 [94]. The method using 96 well-plates allowed the use of a range of metal 
and bacterial concentrations in the same assay. The bacterial concentrations were obtained by 
decimal dilutions of the initial culture and, the ideal concentration to analyse the antibacterial 
activity was selected to allow the detection of bacteria when the test started (0 hours), and to 
avoid optical densities (OD) above 1 in the last measurement, in which the instrument would 
not be so accurate. The ideal concentration of analysis is 0.5 McFarland, which corresponds to 
106 to 108 CFU of E.coli [96]. The initial bacterial culture presented an OD of 0.55, which 
corresponded to 5.3x107 CFU that is inside the range of CFU proposed for 0.5 McFarland. To 
reach an OD about 0.5 in the end of the measurements, it was established that the initial OD 
values should be ranged between 0.05 and 0.1. Furthermore, if the analysis of the bacterial 
growth occur in between the established OD values (0,05-0,5) a linear correlation with cells 
number may be guaranteed, as showed in Figure 33.  The bacterial concentration that satisfied 
these conditions was 10-2. 
 
 
Figure 33- Optical density as a function of bacterial concentration. Error bars represent the standard 
deviation of 8 replicates. The highest concentration was considered 1, and the remaining concentrations 
were dilutions in a factor of 2.  
R² = 0.9976
0
0,1
0,2
0,3
0,4
0,5
0,6
0,7
0 0,2 0,4 0,6 0,8 1 1,2
O
.D
. (
59
5 
nm
)
Relative Bacterial Concentration
72 
 
The bacterial assay was not carried out at 24 hours due to the decrease of bacterial 
growth, probably due to the small volume of each well, which led to depravation of nutrients 
and consequent stop of growth, avoiding a comparison between the normal bacterial growth 
and the inhibition caused by the compounds tested. Also, at 6 hours can already be seen the 
typical bacterial growth curve (Figure 34B), as will be explained later. To every concentrations 
of copper were done 4 replicates without bacteria, representing a negative control, which were 
subtracted to the OD values of every well with the same concentration of copper. Silver nitrate 
was used as a positive control, because of its very well-known antibacterial properties and also 
having higher antimicrobial activities than copper, as explained in the background.  
The development of this method involved the analysis of the normal bacterial growth in 
broth during the period of time analysed. Bacteria tend to grow faster initially, exponential 
growth, and then the growth becomes slower and tends to stabilize as represented by the 
logarithmic curve in Figure 34A. For that reason, the curve with the values obtained for the 
first hours of growth was linearized using the natural logarithm, base e (y = ln(x)), and was 
obtained a great linear correlation as shown in Figure 34C. The curve containing the values for 
the last hours of measurement was linearized using the exponential function (y = ex) and was 
obtained a strongly linear trend again (Figure 34D). The expected bacterial growth was 
confirmed by the developed method, which showed to have a good accuracy for the 
antibacterial tests. The control of contamination of the bacterial cultures was carried out 
regularly by plating the E.coli bacterial growth onto agar plates. No apparent different bacterial 
species were detected by visualization of colonies shape and colour. Although the method was 
not the most accurate to detect contamination, it was an easy procedure to control major 
contaminations. 
 The antimicrobial tests showed that all the compounds caused a reduction in bacterial 
growth, as expected initially. Copper chloride was tested to evaluate the antibacterial activity 
of copper ions (Cu2+), and to provide a comparison between ions and nanoparticles. The results 
showed that both, CuCl2 and Cu(OH)2Tart-Ad, were able to cause a delay in the growth of 
E.coli, which was already reported in previous work, using similar concentrations of copper 
[95]. The same inhibition was obtained for both copper compounds, which probably may be 
explained by the dissolution of Cu(OH)2Tart-Ad nanoparticles, and consequently, the 
inhibition seen was an effect of copper ions in both assays (Figure 35). It was already shown 
that Cu(OH)2Tart-Ad nanoparticles may solubilize when present at low concentrations in broth 
(section 4.1.2).  
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Figure 34– A) Expected bacterial growth curve as a function of time, showing initially a fast growth 
rate, represented by an exponential curve, and then a slower growth represented by a logarithmic curve. 
B) Bacterial growth curve obtained experimentally, with standard errors of 12 replicates. The 
linearization of the two parts of growth showed trendlines with a very high coefficient of correlation:  
Linearization of exponential growth curve (C) and logarithmic growth curve (D).  
 
 
Although there was a possibility of an analytical artefact, these similar results provided 
another evidence about the dissolution of copper nanoparticles. The final inhibition of bacterial 
growth obtained for copper compounds was 58%, which means that copper did not inhibit 
completely the growth of bacteria (Figure 35D). At lower copper concentrations a bactericidal 
effect was not seen. At 1 ppm any differences in bacterial growth were not detected, and at 10 
ppm a very low inhibition was already observed, which may mean that this concentration may 
be very near to the minimum inhibitory concentration (MIC) of copper. The minimum 
bactericidal concentration (MBC) of copper cannot be determined, because this concentration 
is above the highest concentration tested, which was 100 ppm. A further analysis using higher 
concentrations should be done to obtain this value. Also, this analysis showed that copper 
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delayed the normal bacterial growth, but was not understood if copper have an bactericidal or 
bacteriostatic effect, i.e. if copper killed the bacteria, or only inhibited the growth of bacteria 
but did not kill them completely, which may mean that bacteria may regrowth again. Agar 
plates can be prepared with the bacterial cultures that were exposed to copper. If the agar plate 
shows bacteria growth, this may mean that copper only inhibited the bacterial growth, but did 
not kill them. If there are not any bacterial growth, copper may be considered bactericidal.  
A study about the antibacterial activity of copper against E.coli showed that using the 
same concentrations of metal, in liquid culture showed a delay in bacterial growth, whereas in 
solid medium copper inhibit completely the growth. The authors of that investigation proposed 
that in liquid medium the concentration of nanoparticulated copper gradually decreased, which 
allowed the regrowth of bacterial. A reason for that could be the interaction of copper with 
intracellular compounds that were released from the dead bacterial cells [95]. The same effect 
may have occurred during this experiment, and could be a reason for the delay in growth, 
instead of a complete inhibition.  
 Silver nitrate was used to provide Ag+ ions in solution, and to establish a comparison 
with copper compounds tested. Ag+ showed a very high antibacterial activity, even at lower 
concentrations than copper, as already expected. At 10 ppm silver was able to completely 
inhibit the growth of bacteria, almost 100%, while copper presented a very low antimicrobial 
activity at the same concentration (Figure 35C). Furthermore, at 1 ppm a very small reduction 
in bacterial growth was already obtained, showing that the MIC of silver nitrate should be near 
to 1 ppm. Also, a prediction of the MBC of silver which is between 1 and 10 ppm may be 
done. 
 The different activity of copper and silver was suggested to be due to different 
affinities to the cell membrane, leading to a closer interaction with bacteria and consequently a 
better efficacy [25]. These authors suggested that this affinity to cell membrane may be the 
responsible for the different bactericidal activities of copper and silver against different 
bacterial strains, because of their different cell membrane composition. This fact may lead to 
consider that silver presented a higher affinity for bacterial membrane of E.coli than copper, 
but this should not be the only factor to have in consideration. Also, the metabolism of copper 
and silver in bacteria is very important for the toxicity caused by these components, because it 
may determine the response of bacteria to high amounts of these metals in the environment, 
and a resistance mechanism for copper ions was already described, and was also proposed to be 
used for silver ions [49].  
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 In summary, a method for high throughput determination of antibacterial compounds 
was tested effectively and can be used for antimicrobials in solutions or suspensions. Although, 
all the compounds tested presented an antibacterial effect against E.coli, the antimicrobial 
results showed that Cu(OH)2Tart-Ad and CuCl2 presented similar results, which may be an 
indication that copper hydroxides nanoparticles were dissolved, and consequently the activity 
of nanoparticles were not evaluated.  
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Figure 35- Bacterial growth of E.coli in the presence of CuCl2 (A), Cu(OH)2Tart-Ad (B) and silver 
nitrate (C). The graph D shows the growth inhibition 6 hours after exposition of bacterial culture of 
E.coli to CuCl2, Cu(OH)2Tart-Ad, both with  copper concentration of 100 ppm, and AgNO3 at 10 ppm 
of  Ag. The error bars represent standard deviations calculated from 4 replicates.  
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5. Conclusion 
In conclusion, copper hydroxides nanoparticles were synthesized using different 
ligands, which were carboxylic acids typically present in food. The synthesis with tartaric acid 
resulted in the highest production of nanoparticulated copper. This was further improved by 
including adipic acid in the synthesis and more than 90% of the total copper was then present 
as nanoparticles. The synthesized Cu(OH)2Tart-Ad nanoparticles presented desirable 
properties, such as a very small size (3-5 nm), and being well disperse. The size could also be 
tailored depending on the final pH of synthesis. However the nanoparticles appear to be 
dissolved in broth when diluted to low concentrations of copper. Attempts were done to 
overcome this problem by synthesizing copper oxides, but the yields for the production of 
nanoparticulated copper were lower. Additionally, modifications of nanoparticles using silicate 
showed that the concentration of silicon was associated to the increase of particles size, which 
was an indication that silicon affected the nanoparticles. However, these silicon-modified 
nanoparticles were still susceptible to dissolution. The entrapment of copper nanoparticles in a 
silica matrix gel was tested as a different approach to the use of copper nanoparticles in 
suspension. Elemental and TEM analysis showed that Cu(OH)2Tart-Ad nanoparticles were 
successfully entrapped and presented a very small size and were disperse. However, some 
methodological constraints prevented the testing of the activity of these materials. Finally, a 
high throughput method to measure antimicrobial activity of several compounds in liquid 
systems was developed. This allowed the assessment of the activity of Cu(OH)2Tart-Ad 
nanoparticles and copper chloride, which were showed to be similar, and thus suggested again 
that Cu(OH)2Tart-Ad nanoparticles dissolved when present in broth and probably most activity 
was due to soluble copper. Soluble silver was also tested as positive control and to establish a 
positive point for further development of antimicrobial agent. 
In summary, this project was successful at establish an initial synthetic methodology for 
the production of copper-based nanoparticles, which allows the future development of new 
ones. Furthermore, a high throughput methodology was developed and implemented 
effectively, which was used to determine the antibacterial activity of nanoparticles and will 
allow the future development of new ones.  
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6. Future work 
 Future work will focus in increase the stability of the nanoparticles produced to avoid 
dissolution, while maintaining their appropriate small size. Possible strategies are the use of 
polymer and liposomes, since these modifications may protect the nanoparticles against the 
instability. Particle size, shape, capping agents, pH, ionic strength, specific ions and ligands 
may affect the stability of nanoparticle. 
Once synthesized, the nanoparticles should have higher antibacterial activities than 
soluble copper, and then they should be characterized to determine the mineral phase of 
nanocrystalline structures. HRTEM may be used for that propose, since this technique allows 
the analysis of an individual nanoparticle. To complement the antibacterial profile of 
compounds synthesized, they can be tested against different species and antibiotic resistant 
strains to confirm the broad spectrum of action of nanoparticles. 
The development of new strategies of application of nanoparticles, such as the 
entrapment in matrices, may also be an alternative to avoid the instability problems seen in 
liquid systems. Furthermore, should be developed a method to determine the antibacterial 
activity of these materials, such as the silica gel with nanoparticles entrapped in the matrix that 
was synthesized during this work.  
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Attachments 
 
Iso-sentist CM 0473 Bacterial broth composition: 
 
Typical Formula* gm/litre  
Hydrolysed casein  11.0  
Peptones  3.0  
Glucose  2.0  
Sodium chloride  3.0  
Soluble starch  1.0  
Disodium hydrogen phosphate  2.0  
Sodium acetate  1.0  
Magnesium glycerophosphate  0.2  
Calcium gluconate  0.1  
Cobaltous sulphate  0.001  
Cupric sulphate  0.001  
Zinc sulphate  0.001  
Ferrous sulphate  0.001  
Manganous chloride  0.002  
Menadione  0.001  
Cyanocobalamin  0.001  
L-Cysteine hydrochloride  0.02  
L-Tryptophan  0.02  
Pyridoxine  0.003  
Pantothenate  0.003  
Nicotinamide  0.003  
Biotin  0.0003  
Thiamine  0.00004  
Adenine  0.01  
Guanine  0.01  
Xanthine  0.01  
Uracil  0.01  
Agar  8.0  
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Antibacterial test:  96 well plate scheme 
